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In preparation for a legal implementation of EU-regulation 1829/2003, the Norwegian Scientific 
Committee for Food Safety (VKM) has been requested by the Norwegian Environment Agency 
(former Norwegian Directorate for Nature Management) and the Norwegian Food Safety Authority 
(NFSA) to conduct final food/feed and environmental risk assessments for all genetically modified 
organisms (GMOs) and products containing or consisting of GMOs that are authorised in the 
European Union under Directive 2001/18/EC or Regulation 1829/2003/EC. The request covers 
scope(s) relevant to the Gene Technology Act. The request does not cover GMOs that VKM already 
has conducted its final risk assessments on. However, the Agency and NFSA requests VKM to 
consider whether updates or other changes to earlier submitted assessments are necessary.  
 
The herbicide-tolerant genetically modified maize NK603 from Monsanto (Unique Identifier 
MONØØ6Ø3-6) is approved under Directive 2001/18/EC as feed since 19 July 2004 (Commission 
Decision 2004/643/EC). Foods and food ingredients derived from NK603 was authorised under Novel 
Foods Regulation (EC) No 258/97 3 March 2005 (Commission Decision 2005/448/EC) (EC 2013).  
 
Genetically modified maize NK603 has previously been risk assessed by the VKM Panel on 
Genetically Modified Organisms (GMOs), commissioned by the NFSA in connection with the 
national finalisation of the procedure of the notification in 2005 (VKM 2005a). NK603 has also been 
evaluated by the VKM GMO Panel as a component of several stacked GM maize events (VKM 
2005b,c,d,e VKM 2007a,b,  VKM 2008a,b, VKM 2009, VKM 2010, VKM 2011, VKM 2012a, VKM 
2013a,b). Due to the publication of new scientific literature and updated guidelines for risk assessment 
of genetically modified plants, the VKM GMO Panel has decided to deliver an updated risk 
assessment of NK603. This updated assessment only covers health and environmental risks with 
regard to maize NK603 in food products.  
 
The risk assessment of maize NK603 is based on information provided by the applicant in the 
notification C/EC/00/01, the applications EFSA/GMO/NL/2005/22 and EFSA/GMO/RX/NK603, and 
scientific comments from EFSA and other member states made available on the EFSA website GMO 
Extranet. The risk assessment also considers other relevant peer-reviewed scientific literature. 
 
The VKM GMO Panel has assessed maize NK603 with reference to its intended uses in the European 
Economic Area (EEA), and according to the principles described in the Norwegian Food Act, the 
Norwegian Gene Technology Act and regulations relating to impact assessment pursuant to the Gene 
Technology Act, Directive 2001/18/EC on the deliberate release into the environment of genetically 
modified organisms, and Regulation (EC) No 1829/2003 on genetically modified food and feed. The 
Norwegian Scientific Committee for Food Safety has also decided to take account of the appropriate 
principles described in the EFSA guidelines for the risk assessment of GM plants and derived food and 
feed (EFSA 2011a), the environmental risk assessment of GM plants (EFSA 2010), selection of 
comparators for the risk assessment of GM plants (EFSA 2011b) and for the post-market 
environmental monitoring of GM plants (EFSA 2011c).  
 
The scientific risk assessment of maize NK603 include molecular characterisation of the inserted 
DNA and expression of novel proteins, comparative assessment of agronomic and phenotypic 
characteristics, nutritional assessments, toxicology and allergenicity, unintended effects on plant 
fitness, potential for gene transfer, interactions between the GM plant and target and non-target 
organisms, effects on biogeochemical processes and evaluations of the post-market environmental 
plan.  
 
It is emphasised that the VKM mandate does not include assessments of contribution to sustainable 
development, societal utility and ethical considerations, according to the Norwegian Gene Technology 
Act and Regulations relating to impact assessment pursuant to the Gene Technology Act. These 
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considerations are therefore not part of the risk assessment provided by the VKM Panel on Genetically 
Modified Organisms.  
 
The genetically modified maize NK603 has been developed to provide tolerance to glyphosate by the 
introduction, via particle gun acceleration, of a gene coding for 5-enolpyruvylshikimate-3-phosphate 
synthase (EPSPS) from Agrobacterium sp. strain CP4 (CP4 EPSPS). 
 
Molecular characterisation  
NK603 was developed for tolerance to glyphosate by the introduction of the gene cp4 epsps from 
Agrobacterium sp. strain CP4. via a particle acceleration method. The molecular characterisation data 
indicate that only one copy of the tandem cp4 epsps cassette is integrated in the DNA of maize 
NK603, and that it is inherited as a dominant, single locus trait. Appropriate analyses of the integration 
site, inserted DNA sequence, flanking regions, and bioinformatics have been performed. No potential 
new ORFs with sequence similarities to known toxins or allergens were detected. The Chi square 
analyses of the segregation results for the glyphosate tolerance trait in the progeny are also consistent 
with a single active site of insertion. The VKM GMO Panel considers the molecular characterisation 
of maize NK603 as adequate.  
 
Comparative assessment 
Comparative analyses of data from field trials located at representative sites and environments in 
North America and Europe indicate that maize NK603 is compositionally, agronomically and 
phenotypically equivalent to conventional maize, with the exception of the glyphosate tolerance 
conferred by the CP4 EPSPS protein.  
 
Food and feed risk assessment 
Whole food feeding studies on rats have not indicated any adverse effects of maize NK603. 
Nutritional feeding studies on broilers, pigs, steers and cows indicate that NK603 is nutritionally 
equivalent to conventional maize. The CP4 EPSPS protein does not show resemblance to any known 
toxins or IgE allergens, nor has CP4 EPSPS been reported to cause IgE mediated allergic reactions.  
An acute oral toxicity test in mice did not indicate toxic effects of purified E. coli produced CP4 
EPSPS protein. However, such a test does not provide any additional information about possible 
adverse effects of maize NK603. 
 
Based on current knowledge, the VKM GMO Panel concludes that maize NK603 is nutritionally 
equivalent to conventional maize varieties, and that it is unlikely that the CP4 EPSPS protein will 




The authorisations of maize NK603 under Directive 2001/18/EC and the Novel Foods Regulation 
(EC) No 258/97 include import and processing of maize NK603 for food and feed uses. Considering 
the intended uses of maize NK603, excluding cultivation, the environmental risk assessment has been 
concerned with accidental release into the environment of viable grains during transportation and 
processing. 
 
The available data indicate that NK603 has no altered survival, multiplication or dissemination 
characteristics, and there are no indications of an increased likelihood of spread and establishment of 
feral maize plants in the case of accidental release into the environment of seeds from maize NK603. 
Maize is the only representative of the genus Zea in Europe, and there are no cross-compatible wild or 
weedy relatives outside cultivation. The VKM GMO Panel considers the risk of gene flow from 
occasional feral GM maize plants to conventional maize varieties to be negligible in Norway. 
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Considering the intended use as food, interactions with the biotic and abiotic environment are not 




Based on current knowledge, the VKM GMO Panel concludes that maize NK603 is nutritionally 
equivalent to conventional maize varieties, and that it is unlikely that the CP4 EPSPS protein will 
introduce a toxic or allergenic potential in food derived from maize NK603 compared to conventional 
maize.  The VKM GMO Panel likewise concludes that maize NK603, based on current knowledge, is 
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I forbindelse med forberedelse til implementering av EU-forordning 1829/2003 i norsk rett, er 
Vitenskapskomiteen for mattrygghet (VKM) bedt av Miljødirektoratet (tidligere Direktoratet for 
naturforvalting [DN]) og Mattilsynet om å utarbeide endelige helse- og miljørisikovurderinger av alle 
genmodifiserte organismer (GMOer) og avledete produkter som inneholder eller består av GMOer 
som er godkjent i EU under forordning 1829/2003 eller direktiv 2001/18, og som er godkjent for ett 
eller flere bruksområder som omfattes av genteknologiloven. Miljødirektoratet og Mattilsynet har bedt 
VKM om endelige risikovurderinger for de EU-godkjente søknader hvor VKM ikke har avgitt 
endelige risikovurderinger. I tillegg er VKM bedt om å vurdere hvorvidt det er nødvendig med 
oppdatering eller annen endring av de endelige helse- og miljørisikovurderingene som VKM tidligere 
har levert. 
 
Den genmodifiserte, herbicidtolerante maislinjen NK603 fra Monsanto (unik kode MONØØ6Ø3-6) 
ble i juli 2004 godkjent til bruk som all annen mais, unntatt som mat eller til dyrking under direktiv 
2001/18/EF (Kommisjonsbeslutning 2004/643/EC). Maislinjen ble videre godkjent til bruk som, eller i 
næringsmidler under Novel Foods-forordningen (EF.) Nr. 258/97 om nye næringsmidler og 
næringsmiddelingredienser i mars 2005 (Kommisjonsbeslutning 2005/448/EC) (EC 2013). Linjen ble 
videre notifisert som eksisterende produkt under forordning 1829/2003/EF i 2004. Godkjenningen av 
NK603 gikk ut i april 2007, og Monsanto har søkt om fornyet godkjenning fram til 2017 (EFSAGMO-
RX-NK603). Det er også søkt om godkjenning av NK603 for dyrking og frøavl under forordning 
1829/2003/EF (søknad EFSA/GMO/NL/2005/22). I mai 2009 publiserte EFSA en felles 
risikovurdering for begge disse søknadene (EFSA 2009b). I tillegg foreligger det søknader om 
godkjenning av hybrider der en eller flere av foreldrelinjene inngår.  
 
Den genmodifiserte maislinjen har tidligere vært vurdert av VKM med hensyn på mulige helseeffekter 
ved bruk som mat og fôr (VKM 2005a). Risikovurderingen ble utarbeidet på oppdrag fra Mattilsynet i 
forbindelse med vurdering av markedsadgang i Norge. I juni 2008 anbefalte Miljødirektoratet 
Miljøverndepartementet å godkjenne NK603 for omsetning som mat og fôr på det norske markedet. 
Saken ligger fortsatt til behandling i departementet. Etablering av nye, reviderte retningslinjer for 
helse- og miljørisikovurderinger av genmodifiserte planter og publisering av ny vitenskapelig litteratur 
har medført at VKM har valgt å utarbeide en ny, oppdatert helse og miljø -risikovurdering av mais 
NK603. Denne oppdaterte risikovurderingen omfatter kun helse og miljø -risiko knyttet til bruk av 
mais NK603 som mat, ikke som fôr. VKMs faggruppe for GMO har også risikovurdert en rekke 
maishybrider der NK603 inngår som en av foreldrelinjene (2005b,c,d,e VKM 2007a,b, VKM 2008a,b, 
VKM 2009, VKM 2010, VKM 2011, VKM 2012a, VKM 2013a,b). 
 
Risikovurderingen av den genmodifiserte maislinjen NK603 er basert på dokumentasjon gjort 
tilgjengelig på EFSAs nettside EFSA GMO Extranet, og relevante uavhengige vitenskapelige 
publikasjoner. Vurderingen er gjort i henhold til tiltenkt bruk i EU/EØS-området, og i 
overensstemmelse med miljøkravene i genteknologiloven med forskrifter, først og fremst forskrift om 
konsekvensutredning etter genteknologiloven. Videre er kravene i EU-forordning 1829/2003/EF, 
utsettingsdirektiv 2001/18/EF (vedlegg 2,3 og 3B) og veiledende notat til Annex II (2002/623/EF), 
samt prinsippene i EFSAs retningslinjer for risikovurdering av genmodifiserte planter og avledete 
næringsmidler (EFSA 2006, 2010, 2011a,b,c) lagt til grunn for vurderingen.  
 
Den vitenskapelige vurderingen omfatter transformeringsprosess og vektorkonstruksjon, 
karakterisering og nedarving av genkonstruksjoner, komparativ analyse av ernæringsmessig kvalitet, 
mineraler, kritiske toksiner, metabolitter, antinæringsstoffer, allergener og nye proteiner. Videre er 
agronomiske egenskaper, potensiale for utilsiktede effekter på fitness, genoverføring og effekter på 
ikke-målorganismer vurdert. 
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Det presiseres at VKMs mandat ikke omfatter vurderinger av etikk, bærekraft og samfunnsnytte, i 
henhold til kravene i den norske genteknologiloven og dens konsekvensutredningsforskrift. Disse 
aspektene blir derfor ikke vurdert av VKMs faggruppe for genmodifiserte organismer. 
 
NK603 uttrykker CP4-EPSPS-proteiner, som et resultat av introduksjon av cp4-epsps-genet fra 
jordbakterien Agrobacterium tumefaciens. Genet koder for enzymet 5-enolpyruvylsikimat-3-
fosfatsyntetase, som omdanner fosfoenolpyruvat og sikimat-3-fosfat til 5-enolpyruvylsikimat-3-fosfat, 
en viktig metabolitt i syntesen av aromatiske aminosyrer. I motsetning til plantens enzym er det 
bakterielle enzymet også aktivt ved nærvær av N-fosfonometylglycin (glyfosat). De transgene 




Mais NK603 ble utviklet for toleranse til glyfosat via introduksjon av genet cp4 epsps fra 
jordbakterien Agrobacterium sp. linje CP4. ved hjelp av en partikkelakselerasjonsmetode.  Data fra 
den molekylære karakteriseringen indikerer at det kun er integrert ett eksemplar av 
ekspresjonskassetten med cp4 epsps - genet i genomet til mais NK603, og at genet og egenskapene er 
dominant og stabilt nedarvet. Passende bioinformatikk og sekvens -analyser er utført av 
integreringssete i plantens genom, og innsatt og flankerende DNA. Bioinformatikk- analysene har ikke 
avdekket potensielle nye åpne leserammer med sekvenslikhet til kjente toksiner eller allergener. 
Segresjonsanalyser for glyfosat-toleranse, ved hjelp av Chi-kvadrat-test, er i overenstemmelse med at 
det kun er integrert ett eksemplar av ekspresjonskassetten med cp4 epsps – genet i mais NK603. 
VKMs faggruppe for genmodifiserte organismer vurderer den molekylære karakteriseringen av mais 
NK603 som tilfredsstillende. 
 
Komparative analyser 
Feltforsøk i Nord-Amerika og Europa viser små eller ingen signifikante forskjeller mellom den 
transgene maislinjen NK603 og korresponderende, nær-isogene kontrollhybrider med hensyn på 
næringsmessige, morfologiske og agronomiske karakterer, med unntak av herbicidtoleranse. 
Resultatene viser ingen indikasjon på at det innsatte genet NK603 har medført utilsiktede endringer i 
egenskaper knyttet til vekst og utvikling hos maisplantene 
 
Helserisiko 
Fôringsstudier utført på rotter har ikke indikert helseskadelige effekter av mais NK603. Fôringsstudier 
utført på produksjonsdyrene: broiler, gris, storfe og melkekyr indikerer at mais NK603 er 
næringsmessig vesentlig lik konvensjonell mais. CP4 EPSPS – proteinet viser ingen likhet til kjente 
toksiner eller allergener, og er heller ikke rapportert å ha forårsaket IgE-medierte allergiske reaksjoner. 
I en akutt toksisitetsstudie utført på mus ble det ikke påvist toksiske effekter av renset E.coli-produsert 
CP4 EPSPS-protein. Denne typen studier anses derimot ikke å gi ytterligere informasjon om mulige 
helseskadelige egenskaper ved mais NK603. 
 
Ut i fra dagens kunnskap konkluderer VKMs faggruppe for GMO at mais NK603 er næringsmessig 
vesentlig lik konvensjonell mais, og at det er lite trolig at CP4 EPSPS proteinet vil introdusere et 





Godkjenningene av genmodifisert mais NK603 omfatter import, prosessering og bruk som/i 
næringsmidler og fôrvarer, og omfatter ikke dyrking. Med bakgrunn i tiltenkt bruksområde er 
miljørisikovurderingen avgrenset til mulige effekter av utilsiktet frøspredning i forbindelse med 
transport og prosessering.  
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Det er ingen indikasjoner på økt sannsynlighet for spredning, etablering og invasjon av maislinjen i 
naturlige habitater eller andre arealer utenfor jordbruksområder som resultat av frøspill i forbindelse 
med transport og prosessering. Risiko for utkrysning med dyrkede sorter vurderes av GMO panelet til 
å være ubetydelig. Ved foreskreven bruk av maislinjen NK603 antas det ikke å være risiko for 
utilsiktede effekter på målorganismer, ikke-målorganismer eller på abiotisk miljø i Norge. 
 
 
Samlet vurdering  
Ut i fra dagens kunnskap konkluderer VKMs faggruppe for GMO at mais NK603 er næringsmessig 
vesentlig lik konvensjonell mais, og at det er lite trolig at CP4 EPSPS proteinet vil introdusere et 
toksisk eller allergent potensiale i mat basert på mais NK603 sammenliknet med konvensjonelle 
maissorter. Faggruppen finner at mais NK603, ut fra dagens kunnskap og omsøkt bruk, er 
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Abbreviations and explanations 
 
ALS Acetolactate synthase, an enzyme that catalyses the first step in the synthesis 
of the branched-chain amino acids, valine, leucine, and isoleucine 
AMPA Aminomethylphosphonic acid, one of the primary degradation products of 
glyphosate 
ARMG   Antibiotic resistance marker gene  
BC Backcross. Backcross breeding in maize is extensively used to move a single 
trait of interest (e.g. disease resistance gene) from a donor line into the 
genome of a preferred or “elite” line without losing any part of the preferred 
lines existing genome. The plant with the gene of interest is the donor parent, 
while the elite line is the recurrent parent. BC1, BC2 etc. designates the 
backcross generation number. 
BLAST Basic Local Alignment Search Tool. Software that is used to compare 
nucleotide (BLASTn) or protein (BLASTp) sequences to sequence databases 
and calculate the statistical significance of matches, or to find potential 
translations of an unknown nucleotide sequence (BLASTx). BLAST can be 
used to understand functional and evolutionary relationships between 
sequences and help identify members of gene families.  
bp   Basepair 
CaMV   Cauliflower mosaic virus 
Codex Set by The Codex Alimentarius Commission (CAC), an intergovernmental 
body to implement the Joint FAO/WHO Food Standards Programme. Its 
principle objective is to protect the health of consumers and to facilitate the 
trade of food by setting international standards on foods (i.e. Codex 
Standards)  
Cp4 epsps Gene from Agrobacterium sp. strain CP4 
CTP   Chloroplast transit peptide 
DAP    Days after planting 
DN Norwegian Directorate for Nature Management (Direktoratet for 
naturforvalting) 
DNA   Deoxyribonucleic acid 
DT50    Time to 50% dissipation of a protein in soil 
DT90    Time to 90% dissipation of a protein in soil 
dw    Dry weight 
dwt    Dry weight tissue 
EC    European Commission/Community 
ECB    European maize borer, Ostrinia nubilalis 
EFSA   European Food Safety Authority 
ELISA   Enzyme-linked immunosorbent assay 
EPSPS   5-enolpyruvylshikimate-3-phosphate synthase 
ERA    Environmental risk assessment 
E-score   Expectation score 
EU    European Union 
fa    Fatty acid 
FAO   Food and Agriculture Organisation  
FIFRA  US EPA Federal Insecticide, Fungicide and Rodenticide Act  
Fitness Describes an individual's ability to reproduce successfully relative to that of 
other members of its population 
fw    Fresh weight 
fwt    Fresh weight tissue 
GAT   Glyphosate N-acetyltransferase 
GLP   Good Laboratory Practices 
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Glyphosate  Broad-spectrum systemic herbicide 
GM    Genetically modified 
GMO   Genetically modified organism 
GMP   Genetically modified plant 
H    hybrid 
ha    Hectare 
ILSI    International Life Sciences Institute 
IPM    Integrated Pest Management 
IRM    Insect resistance management 
Locus   The position that a given gene occupies on a chromosome 
LOD    Limit of detection 
LOQ    Limit of quantitation 
MALDI-TOF Matrix-Assisted Laser Desorption/Ionization-Time Of Flight. A mass 
spectrometry method used for detection and characterisation of biomolecules, 
such as proteins, peptides, oligosaccharides and oligonucleotides, with 
molecular masses between 400 and 350,000 Da 
MCB    Mediterranean maize borer, Sesamia nonagrioides 
mRNA   Messenger RNA 
MT   Norwegian Food Safety Authority (Mattilsynet) 
NDF  Neutral detergent fibre, measure of fibre used for animal feed analysis. NDF 
measures most of the structural components in plant cells (i.e. lignin, 
hemicellulose and cellulose), but not pectin 
Northern blot Northern blot is a technique used in molecular biology research to study gene 
expression by detection of RNA or isolated mRNA in a sample  
NTO    Non-target organism 
Nicosulfuron  Herbicide for maize that inhibits the activity of acetolactate synthase 
Near-isogenic lines  Term used in genetics, defined as lines of genetic codes that are identical 
except for differences at a few specific locations or genetic loci  
OECD   Organisation for Economic Co-operation and Development  
ORF Open Reading Frame, in molecular genetics defined as the part of a reading 
frame that contains no stop codons  
OSL    Overseason leaf 
OSR    Overseason root 
OSWP    Overseason whole plant 
PCR Polymerase chain reaction, a biochemical technology in molecular biology to 
amplify a single or a few copies of a piece of DNA  
R0    Transformed parent 
Rimsulfuron  Herbicide, inhibits acetolactate synthase 
RNA  Ribonucleic acid 
RP    Recurrent parent 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis. Technique to 
separate proteins according to their approximate size 
SAS    Statistical Analysis System 
SD    Standard deviation 
Southern blot Method used for detection of DNA sequences in DNA samples. Combines 
transfer of electrophoresis-separated DNA fragments to a filter membrane and 
subsequent fragment detection by probe hybridisation  
T-DNA Transfer DNA, the transferred DNA of the tumour-inducing (Ti) plasmid of 
some species of bacteria such as Agrobacterium tumefaciens and A. 
rhizogenes. The bacterium transfers this DNA fragment into the host plant's 
nuclear genome. The T-DNA is bordered by 25-base-pair repeats on each end. 
Transfer is initiated at the left border and terminated at the right border and 
requires the vir genes of the Ti plasmid. 
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TMDI   Theoretical maximum daily intake (TMDI) 
TTC   Threshold of toxicological concern 
TI    Trait integration 
U.S. EPA  United States Environmental Protection Agency. 
 
Maize growth stages: Vegetative 
VE: emergence from soil surface 
V1: collar of the first leaf is visible 
V2: collar of the second leaf is visible  
Vn: collar of the leaf number 'n' is visible  
VT: last branch of the tassel is completely visible 
 
Reproductive 
R0: Anthesis or male flowering. Pollen shed begins 
   R1: Silks are visible 
R2: Blister stage, Kernels are filled with clear fluid and the embryo can be 
seen  
R3: Milk stage. Kernels are filled with a white, milky fluid.  
R4: Dough stage. Kernels are filled with a white paste  
R5: Dent stage. If the genotype is a dent type, the grains are dented 
R6: Physiological maturity 
 
Seedling growth (stages VE and V1); Vegetative growth (stages V2, V3... 
Vn); Flowering and fertilization (stages VT, R0, and R1); Grain filling and 
maturity (stages R2 to R6) 
 
Western blot  Analytical technique used to detect specific proteins in the given sample of 
tissue homogenate or extract. It uses gel electrophoresis to separate native 
proteins by 3-D structure or denatured proteins by the length of the 
polypeptide. The proteins are then transferred to a membrane where they are 
stained with antibodies specific to the target protein. 
WHO  World Health Organisation.  
ZM  Zea maize L. 
ZM-HRA A modified version of the native acetolactate synthase protein from maize. 
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The European Commission has granted the following authorisation for maize NK603 (EC 2013):  
 
• The Commission Decision of 19 July 2004 concerning the placing on the market, in 
accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a 
maize product (Zea mays L. line NK603) genetically modified for glyphosate tolerance, to be 
used as any other maize, with the exception of cultivation and uses as or in food (Notification 
C/ES/00/01).  
• The Commission Decision (2005/448/EC) of 3 March 2005, authorising the placing on the 
market of foods and food ingredients derived from genetically modified line maize NK603 as 
novel foods or novel food ingredients, under Regulation (EC) No 258/97.  
 
An application for authorisation of maize NK603 for cultivation, food and feed uses under Regulation 
(EC) No 1829/2003 was submitted by Monsanto in October 2005 (EFSA/GMO/NL/2005/22). The 
application was submitted jointly with an application for renewal of the authorisation of existing feed 
materials and food and feed additives produced from maize NK603, notified as existing products 
under Regulation (EC) 1829/2003 (EFSA/GMO/RX/NK603). The EFSA GMO Panel assessed these 
two applications together, and published its scientific opinion in May 2009 (EFSA 2009b).  
 
Maize NK603 has previously been assessed as food and feed by the VKM GMO Panel commissioned 
by the Norwegian Food Safety Authority in connection with the national finalisation of the procedure 
of the notification in 2005 (VKM 2005a). Due to the publication of new scientific literature and 
updated guidelines for risk assessment of genetically modified plants, the VKM GMO Panel has 
decided to deliver an updated food and environmental risk assessment of NK603. NK603 has also 
been evaluated by the VKM GMO Panel as a component of several stacked GM maize events (VKM 
2005b,c,d,e, VKM 2007a,b,  VKM 2008a,b, VKM 2009, VKM 2010, VKM 2011, VKM 2012a, VKM 
2013a,b). The 90 days public consultation of the market application of NK603 for cultivation 
(EFSA/GMO/NL/2005/22) was conducted before VKM’s assignment from the Norwegian 
Environment Agency, and the VKM GMO Panel did not participate in the official hearing. 
 
Through the Agreement of the European Economic Area (EEA), Norway is obliged to implement the 
EU regulations on GM food and feed (regulations 1829/2003, 1830/2003 et al). Until implementation 
of these regulations, Norway has a national legislation concerning processed GM food and feed 
products that are harmonised with the EU legislation. These national regulations entered into force 15 
September 2005. For genetically modified feed and some categories of genetically modified food, no 
requirements of authorisation were required before this date. Such products that were lawfully placed 
on the Norwegian marked before the GM regulations entered into force, the so-called existing 
products, could be sold in a transitional period of three years when specific notifications were sent to 
the Norwegian Food Safety Authority. Within three years after 15. September 2005, applications for 
authorisation should be sent to the Authority before further marketing. Four fish feed producing 
companies have once a year since 2008, applied for an exemption of the authorisation requirements of 
19 existing products, including maize NK603. These 19 GM events are all authorised in the EU, and 
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Terms of reference 
 
The Norwegian Environment Agency (former Norwegian Directorate for Nature Management) has the 
overall responsibility for processing applications for the deliberate release of genetically modified 
organisms (GMOs). This entails inter alia coordinating the approval process, and to make a holistic 
assessment and recommendation to the Ministry of the Environment regarding the final authorization 
process in Norway. The Directorate is responsible for assessing environmental risks on the deliberate 
release of GMOs, and to assess the product's impact on sustainability, benefit to society and ethics 
under the Gene Technology Act. 
 
The Norwegian Food Safety Authority (NFSA) is responsible for assessing risks to human and animal 
health on deliberate release of GMOs pursuant to the Gene Technology Act and the Food Safety Act. 
In addition, the NFSA administers the legislation for processed products derived from GMO and the 
impact assessment on Norwegian agriculture according to sector legislation. 
 
 
The Norwegian Environment Agency 
 
In preparation for a legal implementation of EU-regulation 1829/2003, the Norwegian Environment 
Agency, by letter dated 13 June 2012 (ref. 2008/4367/ART-BI-BRH), requests the Norwegian 
Scientific Committee for Food Safety, to conduct final environmental risk assessments for all 
genetically modified organisms (GMOs) and products containing or consisting of GMOs that are 
authorised in the European Union under Directive 2001/18/EC or Regulation 1829/2003/EC. The 
request covers scope(s) relevant to the Gene Technology Act. 
 
The request does not cover GMOs that the Committee already has conducted its final risk assessments 
on. However, the Norwegian Environment Agency requests the Committee to consider whether 
updates or other changes to earlier submitted assessments are necessary. 
 
The basis for evaluating the applicants’ environmental risk assessments is embodied in the Act 
Relating to the Production and Use of Genetically Modified Organisms etc. (the Norwegian Gene 
Technology Act), Regulations relating to impact assessment pursuant to the Gene Technology Act, the 
Directive 2001/18/EC on the deliberate release of genetically modified organisms into the 
environment, Guidance note in Annex II of the Directive 2001/18 (2002/623/EC) and the Regulation 
1829/2003/EC. In addition, the EFSA guidance documents on risk assessment of genetically modified 
plants and food and feed from the GM plants (EFSA 2010, 2011a), and OECD guidelines will be 
useful tools in the preparation of the Norwegian risk assessments. 
 
The risk assessments’ primary geographical focus should be Norway, and the risk assessments should 
include the potential environmental risks of the product(s) related to any changes in agricultural 
practices. The assignment covers assessment of direct environmental impact of the intended use of 
pesticides with the GMO under Norwegian conditions, as well as changes to agronomy and possible 
long-term changes in the use of pesticides. 
 
 
The Norwegian Food Safety Authority  
 
In preparation for a legal implementation of EU-regulation 1829/2003, the Norwegian Environment 
Agency has requested the Norwegian Food Safety Authority (NFSA) to give final opinions on all 
genetically modified organisms (GMOs) and products containing or consisting of GMOs that are 
authorised in the European Union under Directive 2001/18/EC or Regulation 1829/2003/EC within the 
Authority’s sectoral responsibility. The request covers scope(s) relevant to the Gene Technology Act.  
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The Norwegian Food Safety Authority has therefore, by letter dated 13 February 2013 (ref. 
2012/150202), requested the Norwegian Scientific Committee for Food Safety (VKM) to carry out 
final scientific risk assessments of 39 GMOs and products containing or consisting of GMOs that are 
authorised in the European Union.  
 
The assignment from NFSA includes food and feed risk assessments of genetically modified 
organisms and their derivatives, including processed non-germinating products, intended for use as or 
in food or feed.  
 
In the case of submissions regarding genetically modified plants (GMPs) that are relevant for 
cultivation in Norway, VKM is also requested to evaluate the potential risks of GMPs to the 
Norwegian agriculture and/or environment. Depending on the intended use of the GMP(s), the 
environmental risk assessment should be related to import, transport, refinement, processing and 
cultivation. If the submission seeks to approve the GMP(s) for cultivation, VKM is requested to 
evaluate the potential environmental risks of implementing the plant(s) in Norwegian agriculture 
compared to existing varieties (e.g. consequences of new genetic traits, altered use of pesticides and 
tillage). The assignment covers both direct and secondary effects of altered cultivating practices.  
 
VKM is further requested to assess risks concerning coexistence of cultivars. The assessment should 
cover potential gene flow from the GMP(s) to conventional and organic crops as well as to compatible 
wild relatives in semi-natural or natural habitats. The potential for establishment of volunteer 
populations within the agricultural production systems should also be considered. VKM is also 
requested to evaluate relevant segregation measures to secure coexistence during agricultural 
operations up to harvesting. Post-harvest operations, transport, storage are not included in the 
assignment.  
 
Evaluations of suggested measures for post-market environmental monitoring provided by the 
applicant, case-specific monitoring and general surveillance, are not covered by the assignment from 






















                        The Norwegian Scientific Committee for Food Safety (VKM)                      13/320 – final  
 
17 







Genetically modified maize NK603 was modified to provide tolerance to the broad spectrum herbicide 
glyphosate, the active ingredient in the proprietary product with the commercial name Roundup. 
Glyphosate inhibits the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), an essential 
enzyme involved in aromatic amino acid synthesis in plants. Blocking the enzyme results in the 
breakdown of the synthesis of aromatic amino acids, ultimately leading to the death of the plant.  
 
In glyphosate-tolerant maize NK603, the herbicide tolerance trait is generated in the plants through the 
addition of a bacterial epsps gene derived from a common soil bacterium, Agrobacterium sp. strain 
CP4 (CP4 EPSPS). The enzyme produced from the CP4 EPSPS gene has a lower affinity for the 
herbicide compared with the maize enzyme, and thus confers glyphosate-tolerance to the whole plant. 
 
Maize NK603 was evaluated with reference to its intended uses in the European Economic Area 
(EEA), and according to the principles described in the Norwegian Food Act, the Norwegian Gene 
Technology Act and regulations relating to impact assessment pursuant to the Gene Technology Act, 
Directive 2001/18/EC on the deliberate release into the environment of genetically modified 
organisms, and Regulation (EC) No 1829/2003 on genetically modified food and feed.  
 
The Norwegian Scientific Committee for Food Safety has also decided to take account of the 
appropriate principles described in the EFSA guidelines for the risk assessment of GM plants and 
derived food and feed (EFSA 2011a), the environmental risk assessment of GM plants (EFSA 2010), 
the selection of comparators for the risk assessment of GM plants (EFSA 2011b), and for the post-
market environmental monitoring of GM plants (EFSA 2011c).  
 
The risk assessment of the genetically modified maize NK603 is based on information provided by the 
applicant in the applications EFSA/GMO/UK/2004/05 and EFSA/GMO/UK/2005/17, and scientific 
opinions and comments from EFSA and other member states made available on the EFSA website 
GMO Extranet. The risk assessment is also based on a review and assessment of relevant peer-
reviewed scientific literature.   
 
It is emphasised that the VKM mandate does not include assessments of contribution to sustainable 
development, societal utility and ethical considerations, according to the Norwegian Gene Technology 
Act and Regulations relating to impact assessment pursuant to the Gene Technology Act. These 
considerations are therefore not part of the risk assessment provided by the VKM Panel on Genetically 
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2 Molecular characterisation 
 
2.1  Information related to the genetic modification 
 
NK603 expresses tolerance to the broad-spectrum agricultural herbicide Roundup (containing the 
active ingredient glyphosate) by the expression of glyphosate-tolerant 5-enolpyruvyl-shikimate-3-
phosphate synthase (EPSPS) enzymes derived from Agrobacterium sp., strain CP4 (CP4 EPSPS). The 
EPSPS enzyme catalyses the penultimate step of the shikimic acid pathway for the biosynthesis of 
aromatic amino acids, which is present in all green plants. Inhibition of this enzyme by glyphosate 
leads to a reduction of aromatic amino acids, interfering with plant growth, and ultimately leading to 
plant death. With the expression of the glyphosate-tolerant CP4 EPSPS enzymes in NK603, the 
continued function of the aromatic amino acid pathway is ensured in the crop, even in the presence of 
the herbicide.  
 
2.1.1 Description of the methods used for the genetic modification 
 
An agarose gel-isolated MluI restriction fragment of plasmid DNA, designated as PV-ZMGT32L, was 
introduced into embryogenic maize cells using the particle acceleration method (Klein et al. 1987; 
Gordon-Kamm et al. 1990). Description for the construction of the restriction fragment and its parent 
plasmid vector PV-ZMGT32 is presented in Fig. 1 and 2. Using the particle acceleration method, 
DNA was precipitated onto microscopic gold particles using calcium chloride and spermidine. A drop 
of the coated particles was then placed onto a plastic macrocarrier, which is accelerated at a high 
velocity through a barrel by the discharge of compressed helium gas. The macrocarrier hits a metal 
screen which stops the flight of the macrocarrier but allows continued flight of the DNA-coated 
particles. The particles penetrate the target plant cells, where the DNA is deposited and incorporated 
into the cell chromosome.  
 
2.1.2 Nature and source of vector used 
 
NK603 was generated using a particle acceleration transformation system and a gel-isolated MluI 
fragment, PV-ZMGT32L, containing a 5- enolpyruvylshikimate-3-phosphate synthase (epsps) gene 
from Agrobacterium sp. strain CP4 (CP4 EPSPS).  
 
The plant expression plasmid vector, PV-ZMGT32, contains two adjacent plant gene expression 
cassettes each containing a single copy of the cp4 epsps gene (Fig.2). The vector also contains an nptII 
bacterial selectable marker gene encoding kanamycin resistance allowing selection of bacteria 
containing the plasmid, and an origin of replication (ori) necessary for replicating the plasmid in E. 
coli. The agarose gel-isolated MluI restriction fragment of plasmid vector, PV-ZMGT32L, utilised for 
transformation of NK603 contains only the cp4 epsps plant gene expression cassettes and does not 
contain the nptII selectable marker gene or origin of replication. 
 
In both plant gene expression cassettes, the cp4 epsps gene is fused to chloroplast transit peptide 
(CTP) sequences based on sequences isolated from Arabidopsis thaliana EPSPS. The CTP targets the 
CP4 EPSPS protein to the chloroplast, the location of EPSPS in plants and the site of aromatic amino 
acid biosynthesis (Kishore & Shah 1988).  
 
In the first gene cassette, the ctp2-cp4 epsps coding sequence is under the control of the 5’ end of the 
rice actin 1 sequence (ract1) containing the promoter and first intron introduced upstream of the CTP 
sequence. The second cassette contains the ctp2-cp4 epsps sequence under the control of the enhanced 
CaMV 35S promoter (e35S). Located between the e35S promoter and the cp4 epsps sequence is the 
intron from the maize hsp70 (heat shock protein), present to increase the levels of gene transcription. 
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In each cassette, the cp4 epsps sequence is joined to the 0.3 kb nopaline synthase 3’ non-translated 
sequence, NOS 3’, which provides the mRNA polyadenylation signal. An origin of replication 
sequence (ori) was present in the plasmid PV-ZMGT32 to allow for its replication in E. coli. 
Following the ori region is the sequence for the enzyme neomycin phosphotransferase type II (nptII). 
This enzyme confers resistance to certain aminoglycoside antibiotics (e.g., kanamycin and neomycin) 
and was used for selection of bacteria during the construction of the plasmid. The coding sequence for 
the nptII gene was derived from the prokaryotic transposon Tn5 and is present under its own bacterial 
promoter. The resulting plasmid was designated PV-ZMGT32 (Fig. 2). The plasmid PV-ZMGT32 was 
amplified in E. coli and purified from bacterial lysates. The cp4 epsps gene expression linear DNA 
fragment was isolated from the plasmid prior to maize transformation experiments by digesting PV-
ZMGT32 with the restriction enzyme MluI (Fig.1). The plasmid backbone (~2.6 kb) and the CP4 
EPSPS expression cassettes (~6.7 kb) were separated by gel electrophoresis and the expression 
cassette fragment was electroeluted from a gel slice. The agarose gel-isolated MluI restriction 
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Table 1.  Summary of the DNA components of the plasmid PV-ZMGT32 
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2.2 Information relating to the GM plant 
 
2.2.1 Description of the trait(s) and characteristics that have been introduced or 
modified 
 
NK603 was developed for tolerance to glyphosate by the introduction of a gene coding for glyphosate 
tolerant 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) from Agrobacterium sp. strain CP4; 
(CP4 EPSPS). Particle acceleration was used to introduce a fragment of DNA isolated from the 
bacterial plasmid vector PV-ZMGT32. 
 
2.2.2 Information on the sequences actually inserted or deleted 
 
Molecular analysis was performed to characterise the inserted DNA in NK603. Genomic DNA was 
analysed using Southern blot analysis to determine the insert number (number of integration sites 
within the maize genome), the copy number (the number of integrated linear DNA fragments used for 
transformation within one insertion site), the integrity of the inserted promoters, coding regions, and 
polyadenylation sequences, and the presence or absence of the plasmid backbone sequence. 
Polymerase chain reaction (PCR) was performed to verify the sequences at the 5’ and 3’ ends of the 
insert. Further, PCR analysis and subsequent DNA sequencing of four overlapping products spanning 
the length of the insert in NK603 were undertaken to confirm the characterisation of the inserted DNA 
in NK603 (Kesterson et al. 2002a, unpublished Monsanto technical report). 
 
The results showed that NK603 contains only one copy of the complete T-DNA, and that the DNA 
sequence of the insert is identical to the plasmid DNA sequence used for transformation. The genome 
of NK603 did not contain any detectable plasmid backbone DNA. Further, the insertion included an 
inversely linked 217 bp fragment of the enhancer region of the rice actin promoter at the 3’ end. The 
217 bp fragment did not contain the elements needed to act as a promoter and does not form part of 
any detectable transcription product. Adjacent to the 217 bp fragment of the rice actin promoter are 
305 bp with homology to chloroplast DNA but without homology to known toxins or allergens. The 
results of the 3’ and 5’ end bioinformatic analyses, which were updated in 2008, demonstrated that in 
the unlikely event that any of the junction polypeptides were translated, they do not share sequence 




2.2.2.1 The size and copy number of all detectable inserts, both complete and partial 
 
The number of integration sites of transgenic DNA in the maize genome was investigated using 
Southern blot analysis. DNA was extracted from young leaf tissue samples from NK603 and non-
transgenic control line B73.  NK603 and B73 genomic DNA were digested with the restriction enzyme 
StuI, which does not cleave within the DNA fragment used for transformation and would cut within 
the plant genomic DNA. This digestion generates a single fragment containing the inserted DNA and 
adjacent plant genomic DNA from NK603 if there is a single insertion in the maize genome. Non-
transgenic genomic DNA spiked with plasmid PV-ZMGT32 was digested with both StuI and ScaI. 
Since StuI does not cleave within PV-ZMGT32, a second restriction enzyme, ScaI, was necessary to 
linearise the plasmid. The plasmid was linearised to facilitate its migration through the gel so that it 
could serve as an accurate size standard. This result suggested that NK603 contains one insertion of 
integrated DNA located within a 23 kb StuI restriction fragment. Due to the size of the StuI restriction 
fragment, it is possible for more than one hybridising band to be located within this fragment. 
However, the data support the conclusion of a single insert. When NK603 genomic DNA is digested 
with XbaI, a restriction enzyme that cleaves only once within the transformation cassette, two border 
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fragments are produced when probed with PV-ZMGT32. If there were more than one insert located 
within the 23 kb StuI fragment, more than two border fragments would be detected. Therefore, it is 
very likely that the genome of NK603 contains only one insert located within a 23 kb StuI restriction 
fragment. 
 
The number of copies of DNA fragments used for transformation inserted into one locus was 
investigated. NK603 test DNA, non-transgenic control DNA, and non-transgenic control DNA spiked 
with plasmid PV-ZMGT32 DNA were digested with the restriction enzyme XbaI followed by 
Southern blotting. The presence of two hybridising bands indicated that NK603 contains only one 
copy of the transformation cassette at the locus of DNA integration. 
 
The results support the assumption that the two inserted cp4 epsps gene cassettes are intact in NK603. 
Two nucleotide changes have occurred in the second of the two cp4 epsps encoding regions of the 
plant insert compared to the plasmid, one of which is silent and the other resulting in a single amino 
acid change in the expressed protein. In addition, a 217 bp fragment containing a portion of the 
enhancer region of the rice actin promoter is inversely linked to the 3’ end of the inserted cp4 epsps 






Figure 3.  Schematic representation of the NK603 insert.  
 
2.2.2.2 The organisation of the inserted genetic material at the insertion site and 
 methods used for characterisation 
 
The structural organisation of the insert in NK603 was analysed by Southern blot analysis.  
Verification of the insert by DNA sequencing was conducted by Kesterson et al. (Kesterson et al. 
2002a, unpublished Monsanto technical report). The results of the molecular characterisation 
established that NK603 contains a single DNA insert, containing one intact copy of the restriction 
fragment PV-ZMGT32L that was used for transformation. DNA sequencing of the insert showed that 
two nucleotide changes had occurred in the second of the two cp4 epsps coding regions of the plant 
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insert compared to the plasmid, one of which is silent and the other resulting in a single amino acid 
change in the expressed protein, which is referred to as CP4 EPSPS L214P. Both nucleotide changes 
have been present in NK603 since its initial transformation.  
 




2.2.2.4 Chromosomal location(s) of insert(s)  
 
Segregation data for nine generations of NK603 progeny indicated the location and stability of the 
inserted DNA. Statistical analysis of the segregation data indicates that the insert in NK603 segregates 




2.3 Information on the expression of the insert  
 
The levels of CP4 EPSPS and CP4 EPSPS L214P proteins in various tissues of NK603, produced 
during the 1999 growing season in the Europe and the 2002 growing season in the USA., were 
estimated using an enzyme-linked immunosorbent assay (ELISA). 
 
In 1999, forage and grain tissues were produced in European field trials at four sites in France and 
Italy. Four replications were used at each of the four sites. The field trials were conducted using 
agronomic practices and field conditions typical of commercial maize cultivation in the EU. CP4 
EPSPS protein levels were measured in maize forage and grain using a validated direct double 
antibody sandwich ELISA method. All protein values are expressed as micrograms (µg) of the specific 
protein per gram (g) of tissue on a fresh weight (fw) basis. 
 
In maize forage, the mean CP4 EPSPS protein level from the four different field sites ranged from 
44.2 – 60.9  µg/g fw. The overall mean CP4 EPSPS protein level in maize forage across all four sites 
was 48.6 µg/g fw. In maize grain, the mean CP4 EPSPS protein level ranged from 2.2 – 13.2 µg/g fw. 
The overall mean CP4 EPSPS protein level in maize grain across all four sites was 8.4 µg/g fw. 
Control maize samples were below the Limit of Detection (LOD) for CP4 EPSPS protein. The values 
represent the sum of both CP4 EPSPS and CP4 EPSPS L214P, as the ELISA analytical method 
recognises both these proteins expressed in NK603.  The levels of CP4 EPSPS in forage and grain are 
















                        The Norwegian Scientific Committee for Food Safety (VKM)                      13/320 – final  
 
24 
Notification C/ES/00/01– Genetically modified maize NK603 
 
Table 2. Summary of the CP4 EPSPS protein levels in tissue from NK603 plants from the      
               European field trials. 
 





Forage (a,c) 46.6 43.6-60.9 
 (8.3)  
Grain (b,c) 8.4 2.2-13.2 
 (5.4)  
1 The mean and standard deviation were calculated from the analyses of tissue samples from NK603 across four sites (n=16). 
2 Minimum and maximum values from the analyses of samples across four sites. 
a Forage tissue: LOD=0.39 µg/g fw. 
b Grain tissue: LOD=0.16 µg/g fw. 
c Values for all non-transgenic control samples were below the LOD specific for that tissue type (n=16). 
 
 
In 2002, test and control samples were produced in USA field trials in Iowa, Missouri, Ohio and 
Nebraska. These field sites were located within major maize growing region of the USA and provided 
a variety of environmental conditions. At each site, three replicate plots containing NK603 and the 
non-transgenic control were planted using a randomised complete block design. Over season leaf 
(OSL), over season root (OSR), pollen forage, forage root and grain tissues were collected from each 
replicated plot at all field sites. CP4 EPSPS protein levels in the different tissue types were estimated 
using a validated direct double antibody sandwich ELISA method. All protein levels for all tissue 
types were calculated on a microgram (µg) per gram (g) fresh weight (fw) basis. Moisture content was 
determined for all tissue types, and all protein levels greater than the assay limit of quantitation (LOQ) 
were converted to a dry weight (dw) value. The control for this study was a traditional maize hybrid 
that provided a background matrix for the analytical evaluation of the CP4 EPSPS protein levels in the 
plant samples. On a dry weight basis, the mean CP4 EPSPS protein levels across four field sites for 
overseason leaf (OSL-1, OSL-3, OSL-4, and OSL-5) tissues were 410, 300, 430, and 400 µg/g dw, 
respectively. The mean CP4 EPSPS protein levels across four field sites for overseason root (OSR-1, 
OSR-3, OSR-4, and OSR-5) tissues were 160, 76, 100, and 99 µg/g dw, respectively. The mean CP4 
EPSPS protein levels across four field sites for forage, forage root, pollen, and grain tissues were 100, 
140, 650, and 14 µg/g dw, respectively. 
 
According to the applicant, the expression levels for forage and grain reported in Tables 2 and 3 are in 
general agreement with the CP4 EPSPS levels measured in forage and grain samples collected from 
six non-replicated and two replicated field trials conducted in 1998 in the USA, previously reported in 
Monsanto’s notification C/ES/00/01 under Directive 2001/18/EC. In these trials, CP4 EPSPS 
expression levels ranged from 18.0 to 31.2 µg/g fw for forage and from 6.9 to 15.6 µg/g fw for grain 
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Table 3. Summary of the CP4 EPSPS protein levels in tissue from NK603 plants from the USA field trials. 
 










OSL-1 60 (7.2) 49-73 410 (78) 310-560 
OSL-3 63 (6.1) 54-76 300 (49) 220-400 
OSL-4 96 (29) 71-160 430 (170) 290-890 
OSL-5 113 (26) 72-150 400 (96) 280-560 
OSR-1 21 (6.7) 13-31 160 (54) 86-250 
OSR-3 13 (3.5) 5.8-19 76 (24) 37-120 
OSR-4 15 (2.6) 11-20 100 (20) 71-140 
OSR-5 17 (3.9) 11-25 99 (32) 60-170 
Forage 32 (12) 15-52 100 (56) 32-200 
Forage Root 23 (6.8) 12-33 140 (53) 75-220 
Pollen 340 (85) 250-460 650 (150) 450-1000 
Grain 12 (2.8) 7.5-16 14 (3.2) 8.5 
 
 
2.3.1 Part of the plant where the insert is expressed 
 
The expression of the CP4 EPSPS proteins occurs throughout the plant since the rice actin and CaMV 
e35S promoters have been shown to drive constitutive expression of the encoded protein in genetically 
modified maize.  
 
 
2.3.2 Expression of potential fusion proteins 
 
Bioinformatics analyses of junctions and flanking regions of the NK603 insert have been performed. 
DNA sequences were translated from stop codon to stop codon for all reading frames. According to 
the applicant, none of the encoded polypeptides shared sufficient sequence similarity to known toxins 
or allergens to indicate any health risk in case they were translated in maize NK603. (Silvanovich et 




2.4 Genetic stability of the insert and phenotypic stability of the GM plant  
 
2.4.1 Genetic stability of the insert in NK603 
 
Southern blot analyses were undertaken to investigate the genetic stability of the inserted DNA in 
maize NK603. Genomic DNA extracted from leaf tissues of the F1 generation (the progeny from a R0 
back cross) and the fifth generation of back-crossing (BC5F1) of maize NK603 and both control 
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samples were appropriately cleaved, and probed with the full-length ctp2-CP4 epsps fragment. No 
significant differences in banding patterns were observed between DNA extracted from the F1 
generation and the BC5F1 generation of NK603, indicating stability of the inserted DNA in samples 
spanning five generations. This is consistent with a single site of integration into the genomic DNA of 
NK603.These results demonstrate that the integrated segment in maize NK603 is stable spanning at 
least five generations 
 
2.4.2 Phenotypic stability of the GM plant 
 
The inheritance of glyphosate tolerance in the progeny of the original transformant was studied in six 
generations of backcrossing with the commercial inbred maize line B73. Statistically analysed 
segregation data for the six generations, based on the frequency of observed versus expected numbers 
of progeny with tolerance to glyphosate, are presented in Table 4. All generations segregated as 
anticipated for a single insertion site, except the BC2F1 generation. As a possible explanation, the 
applicant states that the higher number of positive (containing the cp4 epsps gene) plants in the BC2F1 
generation may be explained by gamete selection as a result of high application rates of glyphosate in 
the generation prior to the BC2F1 (i.e., BC1F1). Preferential selection for positive gametes has been 
documented in plants when selective agents such as herbicides have been applied (Sari-Gorla et al. 
1994; Touraev et al. 1995). The glyphosate tolerance was studied in three additional generations of 
progeny, created by self-fertilisation of heterozygous glyphosate tolerant plants (Table 4). In these 
cases no significant differences were found from the expected 1:2:1 distribution for the homozygous 
tolerant, heterozygous tolerant and homozygous sensitive plants, respectively. 
 
 





Positive Negative Segregating Positive Negative Segregating ChiSq 
BC0F1 14 15  14.5 14.5  0.00
ns 
BC1F1 32 23  27.5 27.5  1.16
ns 
BC2F1 135 81  108.0 108.0  13.00** 
BC2F2 86 26  84.0 28.0  0.12
ns 
BC2F3 9 16 24 12.3 12.3 24.5 2.02# 
BC3F1 44 45  44.5 44.5  0.00
ns 
BC4F1 127 103  115.0 115.0  2.30
ns 
BC4F3 12 5 17 8.5 8.5 17.0 2.88# 
BC5F1 26 35  30.5 30.5  1.05
ns 
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NK603 was developed for tolerance to glyphosate by the introduction of the gene cp4 epsps from 
Agrobacterium sp. strain CP4. via a particle acceleration method. The molecular characterisation data 
indicate that only one copy of the tandem cp4 epsps cassette is integrated in the DNA of maize 
NK603, and that it is inherited as a dominant, single locus trait. Appropriate analyses of the integration 
site, inserted DNA sequence, flanking regions, and bioinformatics have been performed. No potential 
new ORFs with sequence similarities to known toxins or allergens were detected. The Chi square 
analyses of the segregation results for the glyphosate tolerance trait in the progeny are also consistent 
with a single active site of insertion. The VKM GMO Panel considers the molecular characterisation 
of maize NK603 as adequate.  
 
 
3 Comparative assessment 
 
3.1 Choice of comparator and production of material for the 
compositional assessment 
 
3.1.1 Experimental design and statistical analysis 
 
Compositional analyses were conducted for forage and grain samples collected from NK603 that was 
grown in field trials at multiple locations in the USA in 1998 and in the EU in 1999.  
 
USA field trials  
Compositional analyses were conducted on key maize tissues produced from 8 field trials in 
commercial maize-growing regions of the USA in 1998. Two replicated trials were performed in 
Illinois and Ohio and six non-replicated trials were performed in Iowa, Illinois, Indiana, and Kansas.  
Six genetically modified test lines, one of which was NK603, and the control line were planted at each 
site. According to the applicant, maize event NK603 in an LH82 inbred background was crossed with 
the non-transgenic inbred line, B73, to form the test hybrid. A hybrid formed from the cross of two 
related non-transgenic inbreds, LH82 and B73, both of which lacked the cp4 epsps gene, was used as 
the non GM-control. No conventional commercial reference varieties were included in the field trials 
and the comparative assessments. Comparisons with baseline data on commercial maize, compiled 
from publicly available literature, have been used in the comparisons with maize NK603 for 
consideration of natural variations. 
 
According to the updated EFSA guidance on risk assessment of food and feed from genetically 
modified plants (EFSA 2011a), there should be at least three appropriate non-GM reference varieties 
of the crop that have a known history of safe use at each site. The test of equivalence is used to verify 
whether the agronomic, phenotypic and compositional characteristics of the GM plant fall within the 
normal range of natural variation. Such a range of natural variation is estimated from a set of non-GM 
reference varieties with a history of safe use (EFSA 2011b) and therefore allows comparisons of the 
GM plant with a similar food or feed produced without the help of genetic modification and for which 
there is a well-established history of safe use. These requirements were however not in place at the 
time of submission.   
 
At the non-replicated field sites, there were two blocks (treated and untreated) separated by a 
minimum buffer of 30 m. The treated block contained six plots, one each for the six test lines, with a 
minimum separation distance of 13 m between plots, and the untreated block contained a single plot 
for the control line.  
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For the non-replicated sites, NK603 and its conventional counterpart were planted in a randomised 
complete block design with four blocks or replicates per site. Each block contained seven plots, one 
each for the seven lines, separated by a minimum distance of 3 m. To decrease inadvertent cross-
pollination between the lines, buffer rows were planted between plots. Each plot was bordered by a 
single row of non-transgenic, commercial maize in order to limit edge effects.  
 
The NK603 plots were treated with three applications of a Roundup herbicide during the growth 
season; at pre-emerge, at early post-emerge (V4-V6 stage) and at late post-emerge (V8-V30). The 
genetic purity of maize plants was maintained by bagging the tassels and ear shoots at anthesis and by 
self-pollinating selected plants by hand in the non-replicated sites and all plants in the replicated sites.  
 
Forage was collected at the late dough/early dent stage, and grain was collected at normal kernel 
maturity. The forage and grain from two of the field sites were of poor quality, caused by weather and 
Ustilago-infestation and were therefore not used in the compositional analysis. 
 
European field trials  
Field trials were conducted in the EU in 1999 at four field sites located in France (3) and Italy (1). 
NK603 and the near-isogenic control were planted at all field sites. In addition to the test and control 
hybrid, a total of 19 different conventional, commercial hybrids (five per site with one hybrid planted 
at two sites) were planted as reference varieties. Due to space limitations at two of the sites in France, 
the test entry maize NK603 and the conventional counterpart were not planted in the same block, and 
therefore an incomplete block design was used for these two sites. Each plot was bordered by a single 
row of non-transgenic, commercial maize in order to limit edge effects. Prior to planting, each site 
prepared a proper seed bed according to local agronomic practices which could include tillage, fertility 
and pest managements practices. Each field location was scouted for agronomic and pest management 
needs including pest arthropods, diseases and weeds. Fertiliser, irrigation, agricultural chemicals and 
other management practices were applied as necessary.  
 
All plants of the test events, control lines and reference hybrids were manually self-pollinated. The 
NK603 plots were treated with Roundup herbicide (containing 360 g/L glyphosate acid equivalent), 
with a single broadcast spray application at a rate of 3 L/ha, when a majority of the maize plants were 




Analytes that had > 50 % (1998 data) or > 85 % (1999 data) of values at or below the LOD of the 
assay were excluded from statistical analyses. In 1998, statistical analysis was conducted on 51 
components analysed for three sets of comparisons, these being each of the two replicated trials and a 
combination of trials at different field sites. In 1999, statistical analysis was conducted using a 
randomised complete block model analysis of variance for three further sets of comparisons, these 
being each of the two replicated trials and data from the combination of both trials. Therefore, a total 
of 153 comparisons between NK603 and the non-transgenic control line were made for each year. In 
these analyses, NK603 was compared to the non-transgenic control line LH82 × B73 to determine 
statistically significant differences at p < 0.05. Since a randomised complete block design was not 
possible for 1999 replicated trials at two of the sites in the EU, descriptive statistics including means, 
standard errors (S.E.) and the range of values were reported.  
 
Compositional analysis data for the commercial reference lines were not included in the statistical 
analysis of variance. However, the range of the reference values was determined for each component.  
 
For each analytical component, tolerance intervals were calculated which were expected to contain, 
with 95% confidence, 99% of the values expressed in the population of commercial references. 
                        The Norwegian Scientific Committee for Food Safety (VKM)                      13/320 – final  
 
29 
Notification C/ES/00/01– Genetically modified maize NK603 
 
Because negative quantities are not possible, calculated lower tolerance bounds that were negative, 
were set to zero. A comparison of NK603 to the 99% tolerance interval for the commercial reference 
varieties was conducted to determine if the range of values for NK603 fell within the population of 
commercial maize 
 
An additional statistical evaluation of the compositional analyses of NK603 across all four EU trial 
sites was conducted. This ‘meta-analysis’ compared the individual standardised differences of NK603 
and its conventional control within each site and in a combination of all four field trial sites. The 
means and standard errors for each analyte at each site were taken from the tables in the original 
statistical report and were used to generate the data needed for input into the software, Comprehensive 
Meta Analysis™ (1999). These statistical analyses were conducted for five sets of comparisons: 
analyses for each of four replicated EU trials and for a combination of trials across all field sites. 




3.2 Compositional Analysis 
 
USA trials (1998) 
Compositional analyses were performed for forage and grain tissues collected from NK603 and a non-
transgenic control line grown under field conditions at eight locations in the USA in 1998. The 
compounds analysed were selected based on OECD guidance. Grain samples were analysed for 
proximates (protein, fat, ash, and moisture), acid detergent fibre (ADF), neutral detergent fibre (NDF), 
amino acid, fatty acid, vitamin E, mineral (calcium, copper, iron, magnesium, manganese, phosphorus, 
potassium, sodium and zinc), phytic acid and trypsin inhibitor content. Forage samples were analysed 
for proximates, ADF and NDF content. Carbohydrate values in forage and grain were estimated by 
calculation. The same methods were used for the analyses of proximates in forage and grain except for 
the analysis of fat. In all, 51 different components (7 in forage and 44 in grain) were evaluated as part 
of the compositional assessment of NK603 (Tables 1 and 2, Appendix). Statistical analysis of the field 
trial data revealed one significant difference in 1998, for stearic acid in grain. This difference was 
minor (NK603: 1.95% of total fatty acids; control: 1.86%) and was not observed in 1999. Fifteen 
components (sodium, 8:0 caprylic acid, 10:0 capric acid, 12:0 lauric acid, 14:0 myristic acid, 14:1 
myristoleic acid, 15:0 pentadecanoic acid, 15:1 pentadecenoic acid, 16:1 palmitoleic acid, 17:0 
heptadecanoic acid, 17:1 heptadecenoic acid, 18:3 gamma linolenic, 20:2 eicosadienoic acid, 20:3 
eicosatrienoic acid, and 20:4 arachidonic acid) are not listed in the tables since they had > 50 % of 
values below the LOD of the assay.  
 
EU trials (1999)  
Compositional analyses were performed for key maize tissues collected from NK603, the non-
transgenic control and commercial reference hybrids grown under field conditions at four locations in 
the EU in 1999. Forage and grain samples were collected from all sites. The composition of maize 
NK603 and the non-GM control maize was compared with regard to 7 parameters in forage and  44 in 
grain (Tables 3 and 4, Appendix). The analysed parameters in grain were ash, carbohydrates, fibre, 
moisture, protein, total fat, amino- and fatty acids, minerals (Ca, Cu, Fe, K, Mg, Mn, Na, P, Zn), 
vitamin E, phytic acid and trypsin inhibitor, whereas forage was analysed for proximates and neutral 
and acid detergent fibre. Tissue samples were also collected from a large number of commercially 
available non-transgenic reference hybrids that were grown at the same locations as the test and 
control hybrids. Compositional analyses were conducted to measure proximates (protein, fat, ash, 
carbohydrate, moisture), acid detergent fibre (ADF), neutral detergent fibre (NDF), amino acids, fatty 
acids, vitamin E, minerals (calcium, copper, iron, magnesium, manganese, phosphorus, potassium, 
sodium and zinc), phytic acid and trypsin inhibitor content of grain; as well as proximates, ADF and 
NDF content of forage.  
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The biological relevance of the statistically significant differences was further assessed by performing 
additional comparisons of the level of these compounds in maize NK603 and conventional non-GM 
maize lines grown in field trials conducted in 1994-1995 or 1998. No conclusive differences requiring 
further studies were found. Fifteen components (sodium, 8:0 caprylic acid, 10:0 capric acid, 12:0 
lauric acid, 14:0 myristic acid, 14:1 myristoleic acid, 15:0 pentadecanoic acid, 15:1 pentadecenoic 
acid, 16:1 palmitoleic acid, 17:0 heptadecanoic acid, 17:1 heptadecenoic acid, 18:3 gamma linolenic, 
20:2 eicosadienoic acid, 20:3 eicosatrienoic acid, and 20:4 arachidonic acid)  are not listed in the 
tables since > 85 % of the observations were at or below the LOD of the assay. 
 
Statistical evaluation showed that there were no statistically significant differences in 126 of the 153 
comparisons made between NK603 and the non-transgenic control. Five of the statistically significant 
differences identified were assessed in more detail (phosphorus, leucine, zinc, protein and 
carbohydrate levels in grain). As differences were modest, not observed at other trials, and the levels 
were within the range identified in conventional maize varieties and reported in the literature, also 
these statistically significant differences were not considered biologically relevant. Of the 27 
comparisons found to be statistically different for the E.U. trials, 5 % or approximately eight 
differences, were expected to be false positives based on chance alone. Differences that were observed 
for only one or two of these comparisons, and not consistently across all three comparisons, are 
unlikely to be of biological significance. The differences between the test product and the control 
expressed as percent of the control values ranged between 1.13 % and 22.93 %. Furthermore, the 
range of values for those compositional components associated with the small statistically significant 
differences were all found to fall within the 99 % tolerance interval for commercial reference varieties 
planted at the same EU sites in 1999. This indicates, with a confidence level of 95 %; that the levels of 
key nutrients and other biochemical components for NK603 were within the same population as 
expected for non-transgenic commercial reference maize used in the study. 
 
An additional statistical meta-analysis was conducted. This evaluation compared the standardised 
individual differences of NK603 and its control within each site and in a combination of all four field 
trial sites. This analysis showed that there were no statistically significant differences in 212 of the 255 
comparisons made between NK603 and the control. There were no statistically significant differences 
between NK603 and the control for forage. In grain, statistically significant differences (p < 0.05) 
between NK603 and control were found in 43 of the comparisons. In 39 of these 43 comparisons, the 
range of values for NK603 lay within the 99% tolerance interval of the population of commercial 
reference varieties planted at the same EU sites in 1999. This indicates (confidence level of 95%) that 
the levels of key nutrients and other biochemical components for NK603 were within the sample 
population expected for traditional maize. The four analytes with statistically significant differences 
and with values that were outside the 99% tolerance interval were: phosphorous and glycine, protein 
and carbohydrate. However, these differences were only observed in 1 - 4 of the comparisons and not 
consistently across all five comparisons, and are unlikely to be of biological significance.  
 
Proximates, fibres, and minerals  
The results from the USA and EU field trials demonstrate that the levels of proximate components 
(protein, ash, carbohydrate), fibres (ADF and NDF), and minerals (calcium, copper, iron, magnesium, 
manganese, phosphorus, and zinc) in forage and grain of NK603 were comparable to forage and grain 
of the non-transgenic control (Tables 5 and 6, Appendix). These values were also either within 
published literature ranges, within the tolerance interval determined for commercial varieties evaluated 
in the 1999 field trials, or within the range of historical conventional control values determined from 
previous studies. No measurable differences were observed for the content of fat or potassium in 
forage data from either 1998 or 1999 field trials or the grain data from the 1998 field trials. Even 
though the contents of fat and potassium in the grain of NK603 were statistically significantly 
different from those in the non-transgenic control in data from 1999 field trials, the range of values for 
both analytes of NK603 fell within the 99% tolerance interval for the commercial varieties grown at 
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the same field trials. These results show (confidence level of 95%) that the levels of fat and potassium 




The content of the 18 amino acids measured in grain of maize NK603 was comparable to that in the 
grain of the non-transgenic control (Table 7, Appendix). The values were either within published 
literature ranges, within the 99% tolerance interval for commercial varieties evaluated in 1999 field 
trials, or within the range of historical conventional control values determined from previous studies. 
No statistically significant differences were observed in the content of the aromatic amino acids, 
phenylalanine, tyrosine, and tryptophan, between NK603 and the non-transgenic control in either 1998 
or 1999 field trials. A majority of the amino acids in NK603 were comparable to the control in the 
1999 field trials. However, small statistically significant differences (1.1-6.4%) were observed for 
alanine, arginine, glutamic acid, histidine, lysine, and methionine (p < 0.05). No differences were 
found for these amino acids in the 1998 field trials, and in all cases the range of values found for 
NK603 fell within the 99% tolerance interval for conventional commercial varieties grown in the same 
field trials. The results show that the levels of these amino acids were within the same population as 
those of non-transgenic, commercially available maize hybrids (confidence level of 95%). 
 
Fatty acids  
The content of the fatty acids in grain of NK603 was comparable to that observed in the grain of the 
non-transgenic control (Table 8, Appendix). These values were either within published literature 
ranges, within the 99% tolerance interval determined for commercial hybrids evaluated in 1999 field 
trials, or within the range of historical conventional control values determined from previous studies. 
Statistically significant differences between NK603 and the non-transgenic control were observed in 
the levels of 18:1 oleic acid, 16:0 palmitic acid, and 18:0 stearic acid for the 1998 field trials and 20:0 
arachidic acid in the 1999 trials. In general, the magnitude of the differences was small (2.6-4.8 %), 
and in no case found to be significantly different in NK603 when compared to the control. The ranges 
of values found for these fatty acids were in all cases within the 99% tolerance interval for the 
commercial varieties grown in the 1999 field trials, demonstrating that NK603 was within the same 
population as conventional, commercially available maize hybrids. 
 
Phytic acid, trypsin inhibitor, vitamin E and secondary metabolites 
The content of phytic acid, trypsin inhibitor, and vitamin E in grain from NK603 was comparable with 
that observed in grain of the non-transgenic control (Table 9, Appendix). These values were also either 
within published literature ranges, within the 99% tolerance interval for the commercial varieties in 
the 1999 field trials, or within the range of historical conventional control values determined from 
previous studies. No measurable differences in the levels of these analytes between NK603 and the 
non-transgenic control were observed in the data from the 1998 or 1999 field trials. 
The levels of 2-furaldehyde were below the limit of quantitation (<0.5 ppm of fresh weight) for all 
grain samples analysed from the 1998 field trials. The levels of ferulic acid, p-coumaric acid, and 
raffinose in grain from NK603 were comparable with levels in grain from the non-transgenic control 
No statistically significant differences were observed in the comparisons conducted for the 1998 field 
trials. These secondary metabolites were not analysed in the grain samples from the 1999 trials. 
 
 
3.3 Agronomic and phenotypic characters  
 
Field trials conducted at nine field locations in Germany and France between 2000 and 2002 were 
used for the comparative assessment of phenotypic and agronomic characteristics of maize NK603 
varieties and their appropriate non-GM control maize varieties. The controls did not contain the 
NK603 insert but had similar background genetics to the respective test hybrids.According to the 
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applicant, the field sites provided a range of environmental and agronomic conditions representative of 
a major temperate region for maize production.  
 
The German experiments conducted in 2000 and 2001 were designed as part of larger crop safety 
(selectivity) trials by addition of plots sown with traditional maize controls. Comparative 
characterisation of NK603 and conventional maize varieties was conducted using the data collected 
from the NK603 plots and the traditional comparator plots. The French trials conducted in 2002 were 
specifically designed to assess phenotypic and agronomic characteristics.  
 
All trials were designed as randomised blocks with four replicates and minimum plot dimensions of 24 
m² (3 m × 8 m). NK603 and controls were sown on the same day on dates typical for the region. Maize 
was planted using local planting methods and equipment (drill with precision plate, row width of 75 
cm, sowing depth of 2.5 to 5 cm). After drilling, no glyphosate was applied for weed control in the test 
or control plots. However, a pre-emergence residual herbicide (e.g. atrazine, alachlor, or acetochlor) 
was applied over all plots in certain trials to ensure that the location was weed-free. The two central 
rows of the plots were harvested for yield assessment and pest and disease susceptibility ratings. 
 
During the field trials in Germany and France, phenotypic and agronomic data related to plant growth 
and development, yield, plant morphology, plant health and pest susceptibility were collected. 
Evaluations of the plots were made at different stages during the development of the maize plants. 
Parameters evaluated in these trials included: growth and developmental characteristics (plant stand 
count, % male and female flowering, days to 50% pollen shed, days to 50% silk emergence), plant and 
ear morphology (leaf deformities, leaf colour, plant height, % ear deformations, ear height), plant 
health and vigour indicators and pest susceptibility (vigour, % lodging, susceptibility to insect attack, 
susceptibility to diseases, susceptibility to applied pesticides), and yield characteristics (% barren 
plants without an ear, fresh weight at harvest, grain or forage yield, and % moisture or dry matter at 
harvest). 
 
Where replicated measurements were available for NK603 and control maize, means were calculated 
per trial site. Where appropriate, for each trial site, statistical comparisons were made between the 
means for NK603 and control maize plots at the significance level of p < 0.05 (Student-Newman- 
Keuls). For non-replicated measurements and descriptive observations no statistical analysis was 
performed. 
 
Analyses of variance across trial locations did not indicate differences between NK603 and its 
conventional counterpart. Where statistically significant differences (p < 0.05) were detected, those 
differences were numerically small and did not show any consistent trend across trials or hybrids 
tested.  
 
By-site comparisons between the test and control maize for the nine trial locations did not detect 
statistically significant differences in plant stand count at harvest, number of days from planting to 
50% pollen shed, days from planting to 50% silk emergence, % male flowering, % female flowering, 
% leaf alterations, plant height, % ear deformation and % lodging. Visual inspections of leaf shape, 
susceptibility to insect attack and disease and susceptibility to damage from any pesticides applied at 
any location did not detect differences between the test entry and the control. No statistically 
significant differences were detected for any of the locations in the percentage moisture at harvest 
(grain or total plant), yield at 15% moisture level (for grain maize) or total plant biomass yield as dry 
matter (for forage maize). 
 
For each of the five trials planted in Germany in 2000 and 2001, the growth and developmental 
characteristics, morphological parameters, plant health and vigour indicators, and yield characteristics 
measured were not statistically different between NK603 and traditional maize, with two exceptions. 
A significantly higher average ear height for the NK603 test hybrid (96 cm) was noted in one trial 
                        The Norwegian Scientific Committee for Food Safety (VKM)                      13/320 – final  
 
33 
Notification C/ES/00/01– Genetically modified maize NK603 
 
compared to the traditional control (87 cm). In another trial, a significantly higher average fresh 
weight was noted at harvest for NK603 (86.73 kg/sampled area) compared to the control (80.88 
kg/sampled area), which coincided with a numerical (non-significant) higher moisture level at harvest 
for NK603. These differences were not consistent across the trials, were small in the context of the 
natural biological variability known for maize, and are unlikely to be related to any ecologically or 
agronomically relevant characteristics of NK603 that may be different from the control. 
 
For each of the four French trials planted in 2002, the growth and developmental characteristics, 
morphological parameters, plant health and vigour indicators, and yield characteristics measured were 
not significantly different between the NK603 test and traditional maize, with seven exceptions. In 
three out of four French trials, the early plant count (3-5 leaves stage of maize) prior to thinning was 
significantly higher for traditional maize than for NK603. According to the applicant, the lower 
germination of the NK603 seeds used in this trial is most likely due to differences in seed quality or 
differences in seed treatment. 
 
At one French site, the percent of barren plants lacking an ear was slightly higher for NK603 (4%) 
than for the control (2%). At this site, the ear height at harvest was lower for NK603 (86.6 cm) than 
for the control (96.2 cm), but this difference was not consistent across the trials. In one French trial, 
the plant vigour at the 4-8 leaves stage was slightly higher for the NK603 test hybrid (9.0) than for the 
traditional control (8.3), but this difference was not seen at any of the other sites. These occasional 
differences were not consistent across sites and are not considered biologically meaningful in terms of 
pest potential or adverse plant growth and development. No observed differences or statistically 
significant differences were detected between NK603 and the control for numbers of European maize 
borer (Ostrinia nubilalis) or Sesamia sp. larvae in either the stalks or ears or damage done by these 
borers in any of the five German trials or in the four French trials, respectively. Plant damage was 
measured as total tunnel length in stalks or ears. At one French site, there was a significant difference 
between NK603 (56%) and control maize (76%) for the percent of ears damaged by borers, but this 
difference is thought to have occurred by chance given that the insect pressure at this location was 
rather high. NK603 does not confer a benefit against insect pests. No differences were noted in disease 





Comparative analyses of data from field trials located at representative sites and environments in 
North America and Europe indicate that maize NK603 is compositionally, agronomically and 
phenotypically equivalent to conventional maize, with the exception of the glyphosate tolerance 




4 Food /feed safety assessment 
 
The genetic modification in NK603 maize will not impact the existing production processes used for 
maize. All NK603 maize products will be produced and processed for use in food and industrial 
products in the same way as other commercial maize. The NK603 maize and all food and processed 
products derived from NK603 maize are expected to replace a portion of similar products from 
commercial maize, with total consumption of maize products remaining unchanged. The total 
anticipated intake/extent of use of maize and all food and processed products derived from maize will 
remain the same. 
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4.1 Effects of processing 
 
Food manufacturing includes many harsh processing steps, e.g. cooking, heating, high pressures, pH 
treatments, physical shearing, extrusion at high temperatures etc. under which the majority proteins are 
denatured, which should also apply to the CP4 EPSPS protein. 
 
4.3 Toxicological assessment 
 
4.3.1 Toxicological assessment of the newly expressed proteins 
 
In maize NK603, the only expressed protein product from the inserted gene cassettes is the CP4 




4.3.1.1 Acute oral toxicity testing 
 
Acute oral exposure of CP4 EPSPS protein 
Monsanto has performed an acute toxicity study in mice. Male and female CD-1 mice were dosed by 
gavage with the CP4-EPSPS protein produced in E. coli, purity of the protein was >90 % (Harrison et 
al. 1996). 
 
The study was conducted in general compliance with the EPA FIFRA GLP (40 CFR Part 160), EU-
directive 88/320/EC) and acute oral toxicity guidelines of U.S. EPA and OECD (U.S. EPA Health 
Effects Test Guidelines. OPPTS 870.1100; Acute Oral Toxicity (August 1998), OECD Guideline for 
Testing of Chemicals; Method No. 420: Acute Oral Toxicity-Fixed Dose Method; July 17, 1992). 
 
The protein preparation containing the CP4 EPSPS was administered as a single dose by gavage to 
three groups of the mice at dosages of 49, 154 and 572 mg/kg body weight respectively. These doses 
correspond to 40, 100 and 400 mg/kg of CP4 EPSPS protein based on the level of purity of the protein 
and ELISA analyses of the dosing solutions. A control group received bovine serum albumin (BSA) at 
a dosage of 363 mg/kg in the same solution and delivery volume as the test substance. The second 
control group was administered the carrier solution only, 50 mM sodium bicarbonate. 
 
At defined stages throughout the duration of the study, clinical observations were performed for 
mortality and signs of toxicity, and body weights and food consumption. Signs of toxicity included 
such occurrences as changes in the skin and fur, eyes and mucous membranes, respiratory, autonomic 
and central nervous systems as well as behavioural changes. At the termination of the study (day 8-9), 
animals were sacrificed, examined for gross pathology and numerous tissues were collected. 
 
Tissues retained from the animals included aorta, adrenals, brain, colon, oesophagus, eyes, gall 
bladder, heart, kidneys, lung, liver, lymph nodes, muscle, ovaries, pancreas, pituitary, prostate, rectum, 
salivary gland, seminal vesicles, skin, spinal cord, spleen, stomach, testes, thymus, uterus and bladder. 
Hollow organs were opened and examined. 
 
The results of the study showed no statistically significant differences in group mean body weights, 
cumulative weight gains or food consumption in any of the groups treated with either BSA or the CP4 
EPSPS protein, when compared with the carrier control group. The data were evaluated according to a 
decision-tree analysis procedure which, depending on the results of early statistical tests, determined 
further statistical analysis applied to detect group differences and analyse for trends. All animals 
survived to the scheduled termination of the study, and there were no clinical signs observed that 
could be related to the test material.  
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EHL decision-tree analysis (two-tailed): Terminal body weights were evaluated by decision-tree 
statistical analyses which, depending on the results of tests for normality and homogeneity of 
variances (Bartlett’s,Test), utilised either parametric (Dunnett’s Test) and Linear Regression, or 
nonparametric (Kruskal-Wallis, Jonckheere’s, antior Mann-Whitney) routines to detect differences 
and analysis of trend.  
 




4.3.2 Toxicological assessment of the whole GM food/feed 
 
4.3.2.1 Subchronic (90-day) feeding study on rats 
 
A study was undertaken to compare the responses of Sprague Dawley rats (from Charles River 
Laboratory) when fed either a diet containing grain from maize NK603, or one of several control diets 
containing either grain from the non-transformed parental variety or from one of a series of non-
transformed commercial maize hybrids designated as reference controls (Hammond et al 2004).The 
study design was adapted from OECD Guideline No. 408 (1981) and the study was conducted in 
general compliance with OECD Good Laboratory Practice (GLP) guidelines at the Metabolism and 
Safety Evaluation-Newstead, toxicology laboratory. 
 
Young animals (6 weeks of age, 20 rats/gender/diet group) were assigned to one of the following diets 
for a period of 13 weeks: a). 11% or 33% (wt/wt) NK603 maize; b). 11% or 33% (wt/wt) parental 
control maize; or c). 33% (wt/wt) reference control maize grain (six commercial hybrids tested).  
 
There were a total number of 10 diet groups involving 400 rats in the study. In the diets composed of 
11% test grain (NK603 or parental line), the formulated diet was supplemented with 22% maize grain 
from a non-transformed commercial hybrid to bring the total maize content in these groups to the 
standard 33% used in this experiment. The grain samples and diets were analysed for nutrient 
composition and pesticide and mycotoxin residues. According to the applicant, the experimental diets 
showed that they met the specifications for Certified Rodent LabDiet 5002 established by PMI. Levels 
of heavy metals, aflatoxins, chlorinated hydrocarbons, organophosphate insecticides, and glyphosate 
were all below detection limits. For chlordane, the Covance Laboratories’ limit of detection was 
higher (250 ppb) than the maximum specified concentration of 50 ppb. All diets were balanced for 
similar fat and protein content. 
 
Certified rodent diet was administered during week 1 of the study to establish baseline food 
consumption data for each animal and was followed by administration of the test and control diets 
from weeks 2 to 14. Food consumption was determined daily for days 1, 2, 3 and during days 4-7 for 
each of the first two weeks of the study. Following week 2, food consumption was measured weekly. 
All animals were observed twice daily for morbidity and moribundity. Averaged consumption of feed 
per animal during the study was ~ 21 grams/kg body weight/day, corresponding to ~ 2.3 and ~ 6.9 
grams/kg body weight/day of maize NK603 in the 11% and 33% groups, respectively. Body weight 
was recorded at weekly intervals. After 5 and 14 weeks, blood and urine were collected from 10 
animals/gender/group for blood chemistry, haematology and qualitative and quantitative urine 
analyses. Coagulation parameters were determined at the terminal blood collection only. After 14 
weeks, all animals were sacrificed and necropsied. Specified tissues were collected according to the 
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Observations and results: 
There were two mortalities during the study, one from the high dose NK603 male group (at day 82) 
and the second from a reference control male group (at day 86). Neither death was considered to be 
diet or treatment related. There were no other adverse clinical reactions observed during the course of 
the study. 
 
The results of the herbicide analysis show that the glyphosate residue in the test grain was 0.09 ppm, 
slightly above the analytical detection limit of 0.05 ppm (according to FAO / WHO 2006, MRL for 
Glyphosate in maize is 5 mg/Kg = 5 ppm). The parent and reference lines were not assayed for 
glyphosate. The growth of male and female rats fed NK603 maize grain was comparable to that of rats 
fed grain from the parental control and reference control groups. Body weight gain and food 
consumption were comparable across all groups. At necropsy, no gross lesions were observed that 
were considered to be test article related. The findings observed were randomly distributed among all 
groups and were the type commonly observed in rats of this age and strain. 
 
Organ weights were similar across test and control groups and gross pathology findings were 
unremarkable in test groups and comparable to control groups. The majority of clinical pathology 
parameters (chemistry, haematology, coagulation, urinalysis) were similar across all groups with only 
a few exceptions. A closer examination of the few statistically significant differences in clinical 
parameters demonstrated that these were artefacts of various statistical calculations and were not 
considered biologically meaningful as they were either not dose related, or the values were within the 
range of the reference controls. Microscopic examination of tissues showed no differences between 
rats fed diets containing 33% NK603 maize grain compared to those fed diets with 33% non-
transformed grain. 
 
In summary, the rats fed grain composed of maize line NK603 responded similarly to the animals fed 
parental control and reference control grain diets. 
 
4.3.2.2 Chronic (2-year) feeding study on rats 
 
A two year feeding study performed by Séralini and co-workers (Séralini et al. 2012), was undertaken 
to compare the response of laboratory rats (Sprague Dawley from Harlan laboratory, Gannat, France) 
when fed either a diet containing grain from glyphosate-tolerant maize line NK603 or control diets 
containing grain from the closest isogenic non-transgenic maize control or tap water supplemented 
with Roundup herbicide (R).  
 
In the study, 100 male and 100 female animals were randomly assigned into 10 equivalent groups. For 
each sex, one control group had access to water and standard diet from the closest isogenic non-
transgenic maize control; six groups were fed with 11, 22 and 33% of NK603 maize either treated or 
not with Roundup. The final three groups were fed with the control diet and had access to water 
supplemented with respectively 1.1x10-8 % of Roundup (0.1 ppb of R or 50 ng/L of glyphosate, the 
contaminating level of some regular tap waters), 0.09% of R (400 mg/kg, US MRL of glyphosate in 
some GM feed) and 0.5% of R (2.25 g/L, half of the minimal agricultural working dilution). Animals 
were monitored twice weekly for measurements of food and water consumption, sample collections, 
individual body weights, palpation of animals and recordings of any clinical signs e.g. tumours etc. 
Observations and results: 
According to the study the inclusion of NK603 in the animal feed and/or the use of Roundup herbicide 
either on maize crops or added in drinking water, led to several severe pathologies among the animals, 
including an increased mortality rate, higher rate of tumour development, kidney nephropathies and 
hormone disruptions etc.  
The study by Séralinis group has however been thoroughly investigated by regulatory authorities in 
several countries (e.g. Belgium, Denmark, France, Germany, Italy and the Netherlands) as well as 
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EFSA and The Norwegian Scientific Committees Panel on GMOs (VKM 2012b), and deemed to be of 
such poor scientific quality that the data from the study cannot possibly support the stated findings. 
 
4.4 Allergenicity assessment 
 
Most food allergies are mediated by IgE and are characteristic of type-I reactions.  
The strategies used when assessing the potential allergenic risk focuses on the characterisation of the 
source of the recombinant protein, the potential of the newly expressed protein to induce sensitisation, 
or to elicit allergic reactions in already sensitised individuals and whether the transformation may have 
altered the allergenic properties of the modified food. A weight-of-evidence approach is 
recommended, taking into account all of the information obtained with various test methods, since no 
single experimental method yields decisive evidence for allergenicity (EFSA 2006, EFSA 2011a).  
 
Most of the major food and respiratory IgE-allergens have been identified and cloned, and their 
protein sequences incorporated into various databases. As a result, novel proteins can be routinely 
screened for amino acid sequence homology and structural similarity to known human IgE-allergens 
using an array of bioinformatics tools. Sequence homology searches comparing the structure of novel 
proteins to known IgE-allergens in a database are conducted using various algorithms such as FASTA 
to predict overall structural similarities. According to FAO/WHO (2001) in cases where a novel 
protein and a known IgE-allergen have more than 35% identity over a segment of 80 or greater amino 
acids, IgE cross-reactivity between the novel protein and the allergen should be considered a 
possibility.  
 
4.4.1 Assessment of allergenicity of the newly expressed protein 
 
The applicant has performed a weight-of-evidence approach (Metcalfe et al. 1996; FAO/WHO 2001; 
Codex 2003) for an overall assessment of the IgE allergenic potential of the CP4 EPSPS (and CP4 
EPSPS L214P) protein which includes: 
 
• assessing the allergenicity potential of the source of the gene,  
• homology searches with known protein allergens, 
• susceptibility to in vitro simulated digestion and thermolability, 
• evaluation of protein glycosylation, 
• and assessment of protein exposure  
 
 
The donor organism Agrobacterium sp. strain CP4 is a common soil bacteria and has no history of 
causing allergy. CP4 EPSPS does not resemble any characteristics of known IgE-allergens, and no 
significant homologies between the amino acid sequences of the CP4 EPSPS protein and IgE-
allergenic proteins have been found (Silvanovich et al. 2000; Silvanovich et al. 2002; McCoy et al. 
2002c, from unpublished Monsanto technical report). 
 
The CP4 EPSPS protein is considered heat labile (Hammond et al 2011), it is not glycosylated and is 
readily digested in simulated digestive fluids (Astwood et al 2001; Leach et al 2002a; Leach et al 
2002b, from unpublished Monsanto technical report).  
 
The information listed above indicates that the CP4 EPSPS protein in maize NK603 lacks IgE 
allergenic potential with regard to human and animal health. However, it does not cover allergic 
reactions that are not IgE mediated, e.g. some gluten-sensitive enteropathies or other enteropathies that 
are not IgE-mediated. 
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4.4.2 Assessment of the allergenicity of the whole GM plant 
 
Allergenicity of maize NK603 could be increased as an unintended effect of the random insertion of 
the transgene in the genome of the recipient, e.g. through qualitative or quantitative modifications of 
the expression of endogenous proteins. However, given that no biologically relevant agronomic or 
compositional changes have been identified in maize NK603 or the parental events, with the exception 
of the introduced trait, no increased allergenicity is anticipated for maize NK603. Moreover, maize is 
not considered a common allergenic food.  
 
4.4.3 Assessment of the allergenicity of proteins from the GM plant 
 
The issue of a potentially increased allergenicity of maize NK603 does not appear relevant to the 
Panel since maize is not considered a common allergenic food. Food allergies to maize are of low 
frequency and mainly occur in populations of specific geographic areas. There is no reason to expect 
that the use of maize NK603 will significantly increase the intake and exposure to maize. A possible 
over-expression of any endogenous protein, which is not known to be allergenic, would be unlikely to 




According to the EFSA guidance document for risk assessment of food and feed from GM plants 
(EFSA 2011b), adjuvants are substances that, when co-administered with an antigen increase the 
immune response to the antigen and therefore might increase the allergic response. In cases when 
known functional aspects of the newly expressed protein or structural similarity to known strong 
adjuvants may indicate possible adjuvant activity, the possible role of these proteins as adjuvants 
should be considered. As for allergens, interactions with other constituents of the food matrix and/or 
processing may alter the structure and bioavailability of an adjuvant and thus modify its biological 
activity. No such associations have been reported for CP4 EPSPS.  
 
4.5 Nutritional assessment of GM food/feed 
 
4.5.1 Intake information/exposure assessment 
 
Maize is the most produced food staple in the world. However, net import of maize staple, e.g. flour, 
starch and mixed products, in Norway in 2007 was only 7600 tons, corresponding to 4.4 g dry 
weight/person/day, or an estimated daily energy intake of 0.6 % for adults (Vikse 2009, unpublished). 
The production of maize porridge for children in 2007 was about 37.5 tons, corresponding to a daily 
intake of 1.7 g/day, or an estimated daily energy intake of 0.6 % for a 6 month-old child (Vikse 2009, 
unpublished). In comparison the daily intake in Europe is 8.8 g dry weight/person/day. The expression 
levels of the CP4 EPSPS proteins in grain from maize NK603 ranged from 8.5 - 18 µg/g dw in the 
USA field trials, and 2.6-15.5 µg/g dw in the European field trials.  
Based on these numbers, and that all foods from maize were derived from maize NK603 grain, the 
estimated maximum daily intake for an average Norwegian adult of CP4 EPSPS proteins is calculated 
to be 79.2 µg on a dry weight basis (based on maximum level from US field trials). These levels are 
several orders of magnitude below levels shown to have no effect in laboratory toxicology tests. Also, 
these levels are considerably below the proposed threshold of toxicological concern (TTC) level of 
1800 µg/person/day (Class 1, oral exposure) for chemicals considered to have a low potential for 
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4.5.2 Nutritional assessment of feed derived from the GM plant 
 
Feeding study in Broiler Chickens 
Rapidly growing broiler chickens are sensitive to changes in nutrient quality in diets, and therefore 
serve as a useful model species to evaluate the wholesomeness of protein/amino acid sources. Several 
nutritional performance studies using diets containing 50-63% grain of non- or glyphosate-sprayed 
maize NK603 or conventional herbicide-treated non-GM maize have been carried out with rapidly 
growing broiler chickens, which reach full size within approximately six weeks. 
 
Taylor et al (2003) conducted a study consisting of two 42-day experiments comparing the nutritional 
value of the glyphosate-tolerant maize event NK603 (experiment 1) and the combined insect resistant 
and glyphosate tolerant stacked maize event MON810 × NK603 (experiment 2), to their respective 
non-transgenic controls and to commercial reference maize varieties, when fed to growing broilers. 
Analyses of the diets showed that mycotoxin levels were low and herbicide residues were below the 
maximum levels stipulated by the EU legislation on plant protection products (according to FAO / 
WHO 2006, MRL for Glyphosate in maize is 5 mg/Kg). For each experiment, a randomised complete 
block design was used with eight dietary treatments in each of five replicated blocks of pens (eight 
pens for males and eight pens for females per block. 
 
Final live weights and feed conversion were not different (P > 0.05) across all treatments in both 
experiments. In experiment 1, broilers fed diets containing Roundup Ready maize had similar feed 
conversion adjusted for mortalities to those fed the non-transgenic control and one of the commercial 
maize diets. Chill weights and thigh, drum, and wing weights were not affected by diets. Differences 
(P < 0.05) were noted for breast meat and fat pad weights across treatments. In experiment 2, the 
adjusted feed conversion and carcass parameters were not affected by diets. Differences (P < 0.05) 
were noted only for protein content of breast meat. Differences observed in both experiments were 
consistent with natural variability. Broilers in general performed consistently and had similar carcass 
yields and meat compositions when fed diets containing maize NK603 or MON810 × NK603 as 
compared with their respective non-transgenic control and commercial diets; supporting similar 
feeding values among diets. 
 
A study performed by George B. and co-workers (George B. et al 2001) compared the broiler 
performance and processing parameters of rapidly growing broiler chickens raised on a diet containing 
either maize NK603, the non-transformed parental maize line (B73HTxLH82), or one of five 
commercially available reference maize lines, over approximately 43 days. The broilers, commercial 
strain (Ross x Ross 508), were one day of age at the beginning of the study, and were separated by 
gender and randomly assigned to treatments. For each treatment group, there were 100 birds (50 males 
and 50 females) in 10 pens (10 birds/pen), giving a total of 700 birds. During the course of the study, 
the birds were examined twice daily for general health, and any abnormal health symptoms were 
recorded. 
 
Any birds sacrificed were weighed, and any deaths were necropsied to determine the possible cause of 
death. As much as possible, environmental conditions simulated commercial conditions for raising 
broilers to market weight (around 2 kg) in approximately 43 days. 
 
From days 1-20, chickens were fed a starter diet containing approximately 55% w/w maize (crude 
protein ranging from 20.7% –21.9%). From days 20-42, chickens were fed a grower/finisher diet 
containing approximately 60% w/w maize. These dietary maize concentrations are within the range 
used by commercial poultry growers in the United States. No growth promotants or other medications 
were added to the test diets which were provided ad libitum. 
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The results of the broiler feeding study show that there were no differences in parameters tested 
between birds fed a diet containing maize NK603 and the non-transformed parental line (B73HT x 
LH82). In addition, when individual treatment comparisons were made, broiler chickens in general 
performed and had similar carcass yield and meat composition independent of the diets. The results 
support the conclusion that there are no differences between the non-transformed control and maize 
NK603 in terms of the ability to provide adequate nutrition to rapidly growing broiler chickens. 
 
Dela Cruz et al (2012): This study consist of four 42-day experiments comparing the nutritional value 
of a commercial maize (experiment 1), the combined insect resistant and glyphosate tolerant stacked 
maize event MON 89034 × NK603 (experiment 2), insect resistant maize MON 89034 (experiment 3) 
and maize NK603 (experiment 4). A total of 300, day-old straight-run chicks (Cobb 500) were group-
brooded. After 7 days of brooding, 280 broiler chicks of almost similar body weight (127-128 g) and 
health condition were randomly selected and distributed to 28 cages. Four treatments were randomly 
assigned to the caged birds following a completely randomised design (CRD). Each treatment was 
replicated 7 times with 10 birds per cage and each cage represented a replicate. Birds fed diets with 
any of the GM maize: insect resistant, glyphosate tolerant or combined traits – elicited similar growth 
and efficiency on feed utilisation. However, birds fed diets with the commercial maize performed 
better than those fed diets with GM maize.  
 
According to the authors maize MON89034 x NK603, maize MON89034 and maize NK603 are 
statistically equivalent in proximate composition but lower in crude protein compared to commercial 
maize. 
The carcass yield and organoleptic characteristics of cooked broiler meat, except for tenderness, were 
likewise similar in all groups. Results indicate that the feeding value of maize MON89034 x NK603 
was equivalent to any of the single trait GM maize, though slightly lower compared to the commercial 
maize. 
 
Feeding study in grower and finisher pigs 
Fischer et al (2002): This study compares growth performance and carcass quality measurements in 
growing-finishing pigs provided diets containing maize NK603, the non-transformed control maize, or 
two commercial reference sources of non-genetically modified maize.  
 
The experiment used 72 animals of each gender with an initial body weight of 22.6 ± 0.03 kg. Animals 
were allotted to treatments randomly such that both genders received all four maize hybrids. The 
animals were sacrificed when the average body weight had reached 116 kg. The nutrient composition 
of the maize was similar across all lines used in the study in terms of crude protein and total digestible 
nutrients. Maize was incorporated into the diets at 68.1% (grower1), 74.2% (grower2), 78.1% 
(finisher1) and 81.8% (finisher2), along with de-hulled soybean meal. 
 
Ultrasound measurements of back fat and loin area were taken on the final day of the experiment. 
Carcass quality measurements were made 24 hours post-mortem. Most parameters measured, 
including average daily gain (ADG), average daily feed intake (ADFI) and feed efficiency 
(ADG/ADFI), were not affected by diet but showed an expected difference between the males and 
females. Loin muscle quality and composition (protein, fat and water percentages) were similar among 
diets and between genders. 
 
No differences were observed between the test and control/reference maize lines used in this study in 
terms of growth performance and carcass measurements in growing-finishing pigs.  
 
Hyun et al (2004): Two studies were conducted at two locations to evaluate growth performance and 
carcass characteristics of growing-finishing pigs fed diets containing either maize NK603, a non-
transgenic genetically similar control maize (RX670), or two conventional sources of non-transgenic 
maize (RX740 and DK647). A randomised complete block design (three and four blocks in Studies 1 
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and 2, respectively) with a 2 × 4 factorial arrangement of treatments (two genders and four maize 
lines) was used. Study 1 used 72 barrows and 72 gilts (housed in single-gender groups of six; six pens 
per dietary treatment) with initial and final BW of approximately 22 and 116 kg, respectively. Study 2 
used 80 barrows and 80 gilts (housed in single-gender groups of five; eight pens per dietary treatment) 
with initial and final BW of approximately 30 and 120 kg, respectively. Pigs were housed in a 
modified open-front building in Study 1 and in an environmentally controlled finishing building in 
Study 2. The test maize were included at a fixed proportion of the diet in both studies. Animals had ad 
libitum access to feed and water. Pigs were slaughtered using standard procedures and carcass 
measurements were taken. In Study 1, overall ADG, ADFI (as-fed basis), and gain:feed (G:F) were 
not affected (P > 0.05) by maize line. In Study 2, there was no effect of maize line on overall ADFI 
(as-fed basis) or G:F ratio. In addition, overall ADG of barrows fed the four maize lines did not differ 
(P > 0.05); however, overall ADG of gilts fed maize DK647 was greater (P < 0.05) than that of pigs 
fed the other maize lines. There was no effect (P > 0.05) of maize line on carcass yield or fatness 
measurements in either study. Differences between barrows and gilts for growth and carcass traits 
were generally similar for both studies and in line with previous research. Overall, these results 
indicate that maize NK603 gives equivalent animal performance to conventional maize for growing 
pigs. 
 
Feeding study on Angus-continental cross steers 
Three experiments were conducted to compare the feeding value of genetically modified maize GA21 
and NK603 with non-transgenic hybrids (Erickson et al 2003). Four treatments included two separate 
reference hybrids (REF), the near-isogenic control hybrid (CON), and the genetically modified maize 
(Roundup Ready maize, RR: GA21 or NK603), resulting in two pre-planned comparisons of CON vs. 
RR and RR vs. the average of REF. 
 
In Exp. 1 (GA21), 175 steers (BW = 427 kg) were fed in 25 pens with seven pens per maize hybrid, 
except control (CON), which contained four pens due to limited quantities of that hybrid. 
 
In Exp. 2 (NK603), 196 steers (BW = 420 kg) were fed in 28 pens with seven pens per maize. 
 
In Exp. 3 (NK603), 200 steers were fed in 20 pens, with a similar treatment design to Exp. 2 and five 
pens per maize. 
 
All experiments were conducted as completely randomised designs and utilised maize produced at 
University of Illinois (Exp. 1 and 2) and University of Nebraska (Exp. 3) research farms under 
identity-preserved protocols. 
 
In all experiments, dry matter intake (DMI), average daily gain (ADG), and feed efficiency were 
similar for GM-maize (GA21 or NK603) and the reference hybrids (P > 0.30). In experiments 1 and 2 
the GM-maize did not affect growth performance of steers compared to control maize (P > 0.25). In 
experiment 3, NK603 did not affect ADG or DMI compared to control (P > 0.15), nor feed efficiency 
(P = 0.08). No differences were observed between GM-maize and control, or GM-maize and reference 
hybrids for carcass weight, the longissimus dorsi area, or marbling scores. Fat depth was higher in the 
animals in experiment 3 compared to experiment 1 and 2, however these differences were attributed to 
natural variation. The results indicate that both maize GA21 and NK603 are nutritionally similar to 
conventional maize when fed to finishing feedlot cattle. 
  
 
Feeding study on lactating cows 
Sixteen multiparous Holstein cows averaging 74 d in milk were used in a replicated 4 × 4 Latin square 
to compare the effects on animal performance of feeding whole plant silage and grain from maize 
NK603, a non-transgenic control hybrid, and two commercial non-transgenic hybrids (DK647 and 
RX740), (Ipharraguerre et al 2003). 
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The grain and silage from the four maize hybrids were produced using the same procedures and under 
similar agronomic conditions at the University of Illinois. On a dry matter (DM) basis, diets contained 
30% maize silage and 27.34% maize grain produced either from maize NK603, a non-transgenic 
control, or commercial hybrids. Apart from the DM content of silages, the chemical composition of 
both grain and silage produced from the four maize hybrids were substantially equivalent. 
 
Feeding diets that contained maize NK603 and DK647 hybrids tended to decrease DM intake (DMI) 
compared with the control non-transgenic and RX740. The intakes of crude protein (CP), acid and 
neutral detergent fibre, and non-fibre carbohydrates were not different for cows fed maize NK603 and 
control diets. The RX740 diet resulted in the highest intakes of fibre and CP, whereas the DK647 diet 
resulted in the lowest intake of CP. These differences in nutrient intake arose from small variations in 
both the DMI and the chemical composition of feed ingredients and experimental diets. Production of 
milk and 3.5% fat corrected milk; milk fat, CP, and true protein percentage and yield; milk urea N; 
milk total solids percentage and yield; and somatic cell count were not affected by treatments. These 
data indicate that maize NK603 does not affect lactating dairy cows differently than conventional 
maize. 
 
Grant et al. (2003): Two studies were conducted to evaluate the effect of maize NK603 and maize 
MON863 on feed intake and milk production compared with a non-transgenic hybrid and two 
reference hybrids. 
 
In Experiment 1, 16 multiparous Holstein cows were assigned to one of four treatments in replicated 4 
x 4 Latin squares with 28-d periods. Diets contained 40%, on a dry matter (DM) basis, of either: 1) 
maize NK603 silage (GT), 2) non-transgenic control maize silage, or 3) two non-transgenic reference 
hybrids which are commercially available. Each diet also contained 23% maize grain from the same 
hybrid that supplied the silage. At ensiling, rapid drying conditions prevailed and NK603 was the last 
to be harvested which resulted in greater DM content at similar physiological maturity. The 4% fat-
corrected milk (FCM) yield and DMI were reduced for cows fed the NK603 diet due to the higher DM 
content of the NK603 silage (37.1 vs. 33.2 kg/d and 4.05 vs. 3.61% of BW, respectively). There was 
no effect of NK603 diet on milk composition or efficiency of 4% FCM production that averaged 1.43 
kg/kg of DM intake for all diets. 
 
In Experiment 2, 16 multiparous Holstein cows were assigned to one of four treatments in replicated 4 
x 4 Latin squares with 21-d periods. Diets contained 26.7% (DM basis) maize grain from either: 1) 
maize MON863, 2) non-transgenic control maize hybrid, or 3) the same two non-transgenic reference 
hybrids used in Experiment 1. The 4% FCM yield (34.8 kg/d) and DM intake (4.06% of BW) were 
unaffected by diet. Efficiency of FCM production (average 1.32 kg/kg of DMI) was not affected by 
diet. The two studies indicate that neither maize NK603 nor maize MON863 affected performance of 




Whole food feeding studies on rats have not indicated any adverse effects of maize NK603. 
Nutritional feeding studies on broilers, pigs, steers and cows indicate that NK603 is nutritionally 
equivalent to conventional maize. The CP4 EPSPS protein does not show resemblance to any known 
toxins or IgE allergens, nor has CP4 EPSPS been reported to cause IgE mediated allergic reactions.  
An acute oral toxicity test in mice did not indicate toxic effects of purified E. coli produced CP4 
EPSPS protein. However, such a test does not provide any additional information about possible 
adverse effects of maize NK603. 
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Based on current knowledge, the VKM GMO Panel concludes that maize NK603 is nutritionally 
equivalent to conventional maize varieties, and that it is unlikely that the CP4 EPSPS protein will 





5 Environmental risk assessment 
 
5.1 Potential unintended effects on plant fitness due to the genetic 
modification 
 
Maize (Zea mays L.) is an annual plant and member of the grass family Poacea. The species, 
originating from Central America, is highly domesticated and generally unable to survive in the 
environment without management intervention (Eastham & Sweet 2002).  Maize propagates entirely 
by seed produced predominantly by cross-pollination (OECD 2003). In contrast to weedy plants, 
maize has a pistillate inflorescence (ear) with a cob enclosed with husks. Due to the structure of the 
cob, the seeds remain on the cob after ripening and natural dissemination of the kernels rarely occurs.  
 
The survival of maize in Europe is limited by a combination of absence of a dormancy phase resulting 
in a short persistence, high temperature requirements for germination, low frost tolerance, low 
competitiveness and susceptibility to plant pathogens, herbivores and climatic conditions (van de Wiel 
et al. 2011). Maize plants cannot survive temperatures below 0ºC for more than 6 to 8 hours after the 
growing point is above ground  (OECD 2003), and in Norway and most of Europe, maize kernels and 
seedlings do not survive the winter cold (Gruber et al. 2008). Observations made on cobs, cob 
fragments or isolated grains shed in the field during harvesting indicate that grains may survive and 
overwinter in some regions in Europe, resulting in volunteers in subsequent crops. The occurrence of 
maize volunteers has been reported in Spain and other European regions (e.g. Gruber et al. 2008). 
However, maize volunteers have been shown to grow weakly and flower synchronously with the 
maize crop (Palaudelmás et al. 2009). Cross-pollination values recorded were extremely variable 
among volunteers, most probably due to the loss of hybrid vigour and uniformity. Overall cross-
pollination to adjacent plants was estimated as being low.  
 
Despite cultivation in many countries for centuries, seed-mediated establishment and survival of maize 
outside cultivation or on disturbed land in Europe is rare (BEETLE Report 2009). Maize plants 
occasionally grow in uncultivated fields and by roadsides. However the species is incapable of 
sustained reproduction outside agricultural areas in Europe and is non-invasive of natural habitats 
(Eastham & Sweet 2002; Devos et al. 2009). There are no native or introduced sexually cross-
compatible species in the European flora with which maize can hybridise and form backcross progeny 
(Eastham & Sweet 2002; OECD 2003). The only recipient plants that can be cross-fertilised by maize 
are other cultivated maize cultivars.  
 
It is considered very unlikely that the establishment, spread and survival of maize NK603 would be 
increased due to the herbicide tolerance traits. The herbicide tolerant trait can only be regarded as 
providing a selective advantage for the GM maize plant where and when glyphosate-based herbicides 
are applied. It is considered very unlikely that maize NK603 plants or their progeny will differ from 
conventional maize cultivars in their ability to survive as volunteers until subsequent seasons, or to 
establish feral populations under European environmental conditions.  
 
Field trials carried out by the applicant do not indicate altered fitness of maize NK603 relative to its 
conventional counterpart. A series of field trials with maize NK603 were carried out across nine 
locations in France and Germany between 2000 and 2002. Information on phenotypic (e.g. crop 
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physiology, morphology, development) and agronomic characteristics was provided to assess the 
agronomic performance of maize NK603 in comparison with its conventional counterpart (see section 
3.1). Field data from the European trials did not indicate differences between maize NK603 and the 
corresponding conventional counterpart for the growth, developmental and morphological 
characteristics, agronomic parameters, plant vigour, plant health characteristics, susceptibility to pests 
and diseases. Where statistical differences (p<0.05) were detected, those differences were numerically 
small and did not show any consistent trend across trials or hybrid tested. Moreover, the results were 
within normal variability expected for maize.   
 
In addition to the data presented by the applicant, the VKM GMO Panel is not aware of any scientific 
reports indicative of increased establishment or spread of maize NK603, or changes to its survivability 
(including over-wintering), persistence or invasive capacity. Because the general characteristics of 
maize NK603 are unchanged, glyphosate tolerance is not likely to provide a selective advantage 
outside of cultivation in Europe. The VKM GMO Panel is of the opinion that the likelihood of 
unintended environmental effects based on establishment and survival of maize NK603 will not differ 
from that of conventional maize varieties. 
 
 
5.2  Potential for gene transfer 
 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic material, 
either through horizontal gene transfer of DNA, or vertical gene flow via pollen or seed dispersal. 
Exposure of microorganisms to transgenic DNA occurs during decomposition of plant material 
remaining in the field after harvest or comes from pollen deposited on cultivated areas or the field 
margins. Transgenic DNA is also a component of a variety of food and feed products derived from 
maize NK603. This means that micro-organisms in the digestive tract in humans and animals (both 
domesticated animals and other animals feeding on fresh or decaying plant material from the 
transgenic maize line) may be exposed to transgenic DNA. 
 
Maize is the only representative of the genus Zea in Europe, and there are no cross-compatible wild or 
weedy relatives outside cultivation with which maize can hybridise and form backcross progeny 
(Eastham & Sweet 2002; OECD 2003). Vertical gene transfer in maize therefore depends on cross-
pollination with other conventional or organic maize varieties. All maize varieties which are cultivated 
in Europe can interbreed. In addition, unintended admixture/adventitious presences of genetically 
modified material/transgenes in seeds represent a possible way for gene flow between different 
production systems.  
 
5.2.1 Plant to micro-organisms gene transfer 
 
Experimental studies have shown that gene transfer from transgenic plants to bacteria rarely occurs 
under natural conditions and that such transfer depends on the presence of DNA sequence similarity 
between the DNA of the transgenic plant and the DNA of the bacterial recipient (Nielsen et al. 2000; 
Nielsen 2003; De Vries & Wackernagel 2002, reviewed in EFSA 2004, 2009a; Bensasson et al. 2004; 
VKM 2005f). 
 
Based on established scientific knowledge of the barriers for gene transfer between unrelated species 
and the experimental research on horizontal transfer of genetic material from plants to 
microorganisms, there is today little evidence pointing to a likelihood of random transfer of the 
transgenes present in maize NK603 to unrelated species such as bacteria.   
 
It is however pointed out that there are limitations in the methodology used in these experimental 
studies (Nielsen & Townsend 2004). Experimental studies of limited scale should be interpreted with 
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caution given the scale differences between what can be experimental investigation and commercial 
plant cultivation.  
 
Experiments have been performed to study the stability and uptake of DNA from the intestinal tract in 
mice after M13 DNA was administered orally. The DNA introduced was detected in stool samples up 
to seven hours after feeding. Small amounts (<0.1%) could be traced in the blood vessels for a period 
of maximum 24 hours, and M13 DNA was found in the liver and spleen for up to 24 hours (Schubbert 
et al. 1994). By oral intake of genetically modified soybean it has been shown that DNA is more stable 
in the intestine of persons with colostomy compared to a control group (Netherwood et al. 2004). No 
GM DNA was detected in the faeces from the control group. Rizzi et al. (2012) provides an extensive 
review of the fate of feed-derived DNA in the gastrointestinal system of mammals.  
 
In conclusion, the VKM GMO Panel consider it is unlikely that the introduced gene from maize 
NK603 will transfer and establish in the genome of microorganisms in the environment or in the 
intestinal tract of humans or animals. In the rare, but theoretically possible case of transfer of the CP4 
EPSPS gene from NK603 to soil bacteria, no novel property would be introduced into or expressed in 
the soil microbial communities; as sequence-similar genes are already present in other bacteria in soil. 
Therefore, no positive selective advantage that would not have been conferred by natural gene transfer 
between bacteria is expected. 
 
5.2.2 Plant to plant gene flow 
 
Considering the intended uses of maize NK603 (excluding cultivation) and the physical characteristics 
of maize seeds, possible pathways of gene dispersal are grain spillage and dispersal of pollen from 
potential transgenic maize plants originating from accidental grain spillage during transport and/or 
processing.  
 
The extent of cross-pollination to other maize cultivars will mainly depend on the scale of accidental 
release during transportation and processing, and on successful establishment and subsequent 
flowering of the maize plant. For maize, any vertical gene transfer is limited to other varieties of Zea 
mays plants as populations of sexually compatible wild relatives of maize are not known in Europe 
(OECD 2003). 
 
Survival of maize plants outside cultivation in Europe is mainly limited by a combination of low 
competitiveness, absence of a dormancy phase and susceptibility to plant pathogens, herbivores and 
frost. As for any other maize cultivars, GM maize plants would only survive in subsequent seasons in 
warmer regions of Europe and are not likely to establish feral populations under European 
environmental conditions. In Norway, maize plants from seed spillage occasionally grow on tips, 
waste ground and along roadsides (Lid & Lid 2005). 
 
The flowering of occasional feral GM maize plants origination from accidental release during 
transportation and processing is however unlikely to disperse significant amounts of GM maize pollen 
to other maize plants. Field observations performed on maize volunteers after GM maize cultivation in 
Spain revealed that maize volunteers had a low vigour, rarely had cobs and produced pollen that cross-
pollinated neighbour plants only at low levels (Palaudelmás et al. 2009).  
 
As maize NK603 has no altered survival, multiplication or dissemination characteristics, the VKM 
GMO Panel is of the opinion that the likelihood of unintended environmental effects as a consequence 
of spread of genes from this GM maize in Norway will not differ from that of conventional maize 
varieties. The likelihood of cross-pollination between cultivated maize and the occasional feral maize 
plants resulting from grain spillage is considered extremely low. 
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5.3 Potential interactions between the GM plant and target organisms 
 
Considering the intended uses of maize NK603, excluding cultivation, and the absence of target 
organisms, potential interactions of the GM plant with target organisms were not considered an issue 
by the VKM GMO Panel. 
 
5.4 Potential interactions between the GM plant and non-target organisms 
(NTOs) 
 
Considering the intended uses of maize NK603, excluding cultivation, potential interactions of the 
GM maize with non-target organisms were not considered an issue by the VKM GMO Panel. 
 
 
5.5 Potential interactions with the abiotic environment and biochemical 
cycles 
 
Considering the intended uses of maize NK603, which exclude cultivation, and the low level of 
exposure to the environment, potential interactions of the GM plant with the abiotic environment and 
biogeochemical cycles were not considered an issue by the VKM GMO Panel.  
 
 
5.6 Post-market environmental monitoring  
 
Directive 2001/18/EC introduces an obligation for applicants to implement monitoring plans, in order 
to trace and identify any direct or indirect, immediate, delayed or unanticipated effects on human 
health or the environment of GMOs as or in products after they have been placed on the market. 
Monitoring plans should be designed according to Annex VII of the Directive. According to Annex 
VII, the objectives of an environmental monitoring plan are 1) to confirm that any assumption 
regarding the occurrence and impact of potential adverse effects of the GMO or its use in the 
environmental risk assessment (ERA) are correct, and (2) to identify the occurrence of adverse effects 
of the GMO or its use on human health or the environment which were not anticipated in the 
environmental risk assessment. 
 
Post-market environmental monitoring is composed of case-specific monitoring and general 
surveillance (EFSA 2011c). Case-specific monitoring is not obligatory, but may be required to verify 
assumptions and conclusions of the ERA, whereas general surveillance is mandatory, in order to take 
account for general or unspecific scientific uncertainty and any unanticipated adverse effects 
associated with the release and management of a GM plant. Due to different objectives between case-
specific monitoring and general surveillance, their underlying concepts differ. Case-specific 
monitoring should enable the determination of whether and to what extent adverse effects anticipated 
in the environmental risk assessment occur during the commercial use of a GM plant, and thus to 
relate observed changes to specific risks. It is triggered by scientific uncertainty that was identified in 
the ERA. 
 
The objective of general surveillance is to identify unanticipated adverse effects of the GM plant or its 
use on human health and the environment that were not predicted or specifically identified during the 
ERA. In contrast to case-specific monitoring, the general status of the environment that is associated 
with the use of the GM plant is monitored without any preconceived hypothesis, in order to detect any 
possible effects that were not anticipated in the ERA, or that are long-term or cumulative.  
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No specific environmental impact of genetically modified maize NK603 was indicated by the 
environmental risk assessment and thus no case specific monitoring is required. The VKM GMO 
Panel is of the opinion that the scope of the monitoring plan provided by the applicant is in line with 
the intended uses of maize NK603 since the environmental risk assessment did not cover cultivation 
and identified no potential adverse environmental effects.  
 
 
5.7  Conclusion 
 
The authorisations of maize NK603 under Directive 2001/18/EC and the Novel Foods Regulation 
(EC) No 258/97 include import and processing of maize NK603 for food and feed uses. Considering 
the intended uses of maize NK603, excluding cultivation, the environmental risk assessment has been 
concerned with accidental release into the environment of viable grains during transportation and 
processing, and indirect exposure, mainly through manure and faeces from animals fed grains from 
maize NK603 
 
The data provided suggest that maize NK603 has no altered survival, multiplication or dissemination 
characteristics, and there are no indications of an increased likelihood of spread and establishment of 
feral maize plants in the case of accidental release into the environment of seeds from maize NK603. 
Maize is the only representative of the genus Zea in Europe, and there are no cross-compatible wild or 
weedy relatives outside cultivation. The VKM GMO panel concludes that the risk of gene flow from 
occasional feral GM maize plants to conventional maize varieties is negligible. Considering the 
intended use as food and feed, interactions with the biotic and abiotic environment are not considered 




6 Data gaps  
 
Herbicide residue levels 
Herbicide residue levels on plants with engineered resistance to one or two broad spectrum herbicides 
could entail higher levels of herbicide residue cocktails compared to plants produced by conventional 
farming practices.  
 
Since it is difficult to predict the toxicity of cocktails from the toxicity of the single components, there 
is uncertainty related to risk of confounding effects such as additive or synergistic effects between the 
residues in herbicide resistant plants.  
 
The transgene technology used can possibly lead to different metabolic products of the applied 
herbicides from what is expected from conventional usage. The risk assessment of herbicides should 
take into account plants with altered metabolism.  
 
At present the changes related to herbicide residues of genetically modified plants as a result of the 
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Molecular characterisation  
NK603 was developed for tolerance to glyphosate by the introduction of the gene cp4 epsps from 
Agrobacterium sp. strain CP4. via a particle acceleration method. 
The molecular characterisation data indicate that only one copy of the tandem cp4 epsps cassette is 
integrated in the DNA of maize NK603, and that it is inherited as a dominant, single locus trait. 
Appropriate analyses of the integration site, inserted DNA sequence, flanking regions, and 
bioinformatics have been performed. No potential new ORFs with sequence similarities to known 
toxins or allergens were detected. The Chi square analyses of the segregation results for the glyphosate 
tolerance trait in the progeny are also consistent with a single active site of insertion. The VKM GMO 
Panel considers the molecular characterisation of maize NK603 as adequate.  
 
Comparative assessment 
Comparative analyses of data from field trials located at representative sites and environments in 
North America and Europe indicate that maize NK603 is compositionally, agronomically and 
phenotypically equivalent to conventional maize, with the exception of the glyphosate tolerance 
conferred by the CP4 EPSPS protein.  
 
Food and feed risk assessment 
Whole food feeding studies on rats have not indicated any adverse effects of maize NK603. 
Nutritional feeding studies on broilers, pigs, steers and cows indicate that NK603 is nutritionally 
equivalent to conventional maize. The CP4 EPSPS protein does not show resemblance to any known 
toxins or IgE allergens, nor has CP4 EPSPS been reported to cause IgE mediated allergic reactions.  
An acute oral toxicity test in mice did not indicate toxic effects of purified E. coli produced CP4 
EPSPS protein. However, such a test does not provide any additional information about possible 
adverse effects of maize NK603. 
 
Based on current knowledge, the VKM GMO Panel concludes that maize NK603 is nutritionally 
equivalent to conventional maize varieties, and that it is unlikely that the CP4 EPSPS protein will 
introduce a toxic or allergenic potential in food derived from maize NK603 compared to conventional 
maize. 
 
Environmental assessment  
The authorisations of maize NK603 under Directive 2001/18/EC and the Novel Foods Regulation 
(EC) No 258/97 include import and processing of maize NK603 for food and feed uses. Considering 
the intended uses of maize NK603, excluding cultivation, the environmental risk assessment has been 
concerned with accidental release into the environment of viable grains during transportation and 
processing, and indirect exposure, mainly through manure and faeces from animals fed grains from 
maize NK603 
 
The data provided suggest that maize NK603 has no altered survival, multiplication or dissemination 
characteristics, and there are no indications of an increased likelihood of spread and establishment of 
feral maize plants in the case of accidental release into the environment of seeds from maize NK603. 
Maize is the only representative of the genus Zea in Europe, and there are no cross-compatible wild or 
weedy relatives outside cultivation. The VKM GMO panel concludes that the risk of gene flow from 
occasional feral GM maize plants to conventional maize varieties is negligible. Considering the 
intended use as food and feed, interactions with the biotic and abiotic environment are not considered 
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Overall conclusion 
Based on current knowledge, the VKM GMO Panel concludes that maize NK603 is nutritionally 
equivalent to conventional maize varieties, and that it is unlikely that the CP4 EPSPS protein will 
introduce a toxic or allergenic potential in food derived from maize NK603 compared to conventional 
maize.  The VKM GMO Panel likewise concludes that maize NK603, based on current knowledge, is 
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Table 1.  Fibre and proximate content of forage from USA field trials (1998)  
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Table 2. Amino acid, fatty acid, fibre, mineral, proximate, phytic acid, trypsin inhibitor and vitamin E content of grain from USA           
               field trials (1998) 
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Table 2. Continued 
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Table 3. Fibre and proximate content of forage from EU field trials (1999) 
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Table 4. Amino Acid, Fatty Acid, Fibre, Mineral, Proximate, Phytic Acid, Trypsin Inhibitor and Vitamin E Content of Grain from EU field trials 
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Table 5. Summarised data from USA and EU field trials – fibre, proximates and mineral content of Grain (Ridley et al. 2002) 
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Table 7. Summarised data from USA and EU field trials – amino acids in Grain (Ridley et al. 2002)
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Table 9. Summarised data from USA and EU field trials – content of phytic acid, trypsin inhibitor and vitamin E 
in grain (Ridley et al. 2002) 
 
 
